DEX printout of hierarchical structure of a comprehensive evaluation of BLA
\r\n\texplores a comprehensive overview of the recent theories on flow, transport, industrial applications and processes in porous media. It also extensively discusses sophisticated porous media models which can be used to improve the modeling in practical applications.
\r\n\r\n\tFeaturing contributions from renowned experts in their respective fields, this book,
\r\n\r\n\tDescribes the general characteristics of Modelling and Mechanics in Porous Media, such as multiscale modeling of porous media, two-phase flow, and compressible porous media.
\r\n\r\n\tCovers heat and mass transfer of nanofluids as well as thermal transport in porous media, including natural/forced convection, double-diffusive convection, heat transfer enhancement using nanofluids.
\r\n\tAddresses geological applications in porous media, Transport in Porous media in natural resources and applications in the environment.
\r\n\tDiscusses relevant work experimental work or numerical techniques wherever applicable.
\r\n\tPresents innovative approaches to applying existing porous media technologies to bio-science, biotechnology and biomedical applications.
\r\n\t
In the chapter we are presenting the theoretical background, state of the art and modern research trends of Clinical decision support systems (CDSS). The challenges for success are derived and our experience is described with the presentation of a good practice example of employing CDSS in telemedicine.
\n\t\t\tCDSS systems are increasingly often integrated into telemedicine clinical practice. In addition to using the same resources, namely digitally coded clinical data, CDSS systems are able to enhance the quality of telemedicine services in many cases.
\n\t\t\tCDSS are computer applications that are designed to help health-care professionals with making clinical decisions about individual patients (Shortliffe and Cimino 2006; Berner 2007). In other words, CDSS are active knowledge systems, which use two or more items of patient data to generate case-specific advice (Wyatt and Spiegelhalter 1991).
\n\t\t\tThese kinds of software use relevant knowledge, rules within a knowledge base and relevant patient and clinical data to improve clinical decision making on topics like preventive, acute and chronic care, diagnostics, specific test ordering, prescribing practices (National Electronic Decision Support 2003; Pearson, Moxey et al. 2009). A CDSS correlates data about patient traits with a trustworthy knowledge base to guide a clinician with patient-specific advice, assessments or recommendations. Clinicians, health-care staff or patients can manually enter patient characteristics into the computer systems; alternatively, electronic medical records (EMR) can be queried for retrieval of patient characteristics. These kinds of decision-support systems allow the clinicians to spot and choose the most appropriate treatment. Provided decision-support is based on processes of sophisticated outcomes assessment and algorithms that use knowledge bases to inquire after the newest developments about best practice (Remmlinger 2002; Garg, Adhikari et al. 2005).
\n\t\t\tRegardless of how we choose to define CDSS, we have to accept that the field of CDSS is rapidly advancing and unregulated. It has a potential for harm, if systems are poorly designed and inadequately evaluated, as well as a huge potential to benefit, especially in health care provider performance, quality of care and patient outcomes (Delaney, Fitzmaurice et al. 1999; Pearson, Moxey et al. 2009).
\n\t\tThere are some principal categories to take into account while striving for excellent decision-making: a) accurate data, b) applicable knowledge, c) appropriate problem-solving skills (Shortliffe and Cimino 2006).
\n\t\t\tPatient data must be adequate to make a valid decision. The problem arises, when the clinician is met with an overwhelming amount of specific and unspecific data, which he/she cannot satisfactorily process. Therefore it is important to assess when additional facts will confuse rather than clarify the patient’s case. For example, usual setting for such a problem are intensive-care units, where practitioners must absorb large amounts of data from various monitors, be aware of the clinical status, patient history, accompanying chronic illnesses, patient’s medication and adverse drug interactions, etc. - and on top of that make an appropriate decision about the course of action. The quality of available data is of equal importance. Measuring instruments and monitors should be as accurate as technologically possible, since erroneous data could have serious adverse effect on patient-care decisions.
\n\t\t\tKnowledge used in decision-making process must be accurate and current. It is of major importance that the deciding clinician has a broad spectrum of medical knowledge and access to information resources, where it is possible to constantly revise and validate that knowledge. For a patient to receive appropriate care, the clinician must be aware of the latest evidence-based guidelines and developments in the area of the case in question. It is in clinician’s hands to bring proven therapies from research papers to the bedside. CDSS analogously needs an extensive, well-structured and current source of knowledge to appropriately serve the clinician.
\n\t\t\tAbove all, good problem-solving skills are needed to utilize available data and knowledge. Deciding clinicians must set appropriate goals for each task, know how to reason about each goal and take in to account the trade-offs between costs and benefits of therapy and diagnostics. In further reflection, we should not neglect, that skilled clinicians draw extensively from their personal experience.
\n\t\t\tBy incorporating patient-specific data and evidence-based guidelines or applicable knowledge base, the CDSS can improve quality of care with enhancing the clinical decision-making process (General Practice Electronic Decision Support 2000).
\n\t\t\tIn order to be able to construct applicable CDSS, it is imperative to have a broader-based understanding of medical decision-making as it occurs in the natural setting. Designing CDSSs without understanding the cognitive processes underlying medical reasoning and decision analysis is pliable for ineffectiveness and failure for implementation into everyday clinical workflow (Patel, Kaufman et al. 2002).
\n\t\t\tDecision analysis is a quantitative evaluation of the outcomes that result from a set of choices in a specific clinical situation and is the methodology usually chosen for clinical problem solving. This process is often implicit and occurs within internal algorithms and heuristics (mental shortcuts) that the clinician has developed and acquired over time. Decision analysis, by requiring a specific model structure and assessment of various likelihoods and values of the outcomes, makes the decision process explicit and more inclined to examination, discussion, and re-validation. Decision models are often used as analytic tools to conduct cost-effectiveness analyses, since this methodology can be used to find the expected value of predicted outcomes.
\n\t\t\t\tThe range of clinical problems appropriate for decision analysis is vast. Such problems focus upon a specific decision, where there is a tradeoff involved, which means that one of the choices considered is not necessarily unambiguously superior. As an example, a diagnostic test carries some risk, but it trades off with more appropriate therapy and better patient outcome when treatment is directed by the results of that test. Decision-making is rarely a clear-cut process - it therefore inevitably involves compromises.
\n\t\t\t\tIn general, decision analyses have been developed to:
\n\t\t\t\tAssist in clinical decision-making for a specific individual patient;
Estimate optimal strategies for classes of patients with specific clinical characteristics in given situations;
Link estimates of both clinical and economic outcomes (cost-effectiveness analysis) to help in forming issues regarding health policy;
Provide estimates of expected outcomes in situations where classical methods such as randomized trials are either impossible or impractical.
There are several advantages of using decision analysis to investigate options involving a single patient. Placing the problem in an explicit, analytic context forces clinicians to make their assumptions clear. Decision analyses can directly incorporate issues regarding quality of life and how the particular patient values various outcomes. An example of such a decision analysis is weighing the risks and benefits of prophylactic mastectomy (breast removal) and oophorectomy (removal of ovaries) for patients with BRCA1 or BRCA2 mutations. One has to combine several kinds of data - estimates of the increased risks of ovarian and breast cancer for women with the mutations, general cancer incidence and last but not least, the risks that the surgical procedures impose. The analysis in a certain point of time demonstrates, using the best currently available data, that life expectancy for women who carry such mutations was increased by as much as 5.3 years with prophylactic mastectomy and by as much as 1.7 years with prophylactic oophorectomy.
\n\t\t\t\tDeveloping and constructing a decision analysis follows a logical series of steps (problem-solving). Problems or errors in any step can alter the eventual results; thus, proper adherence to each of these steps is important both from the view of a researcher conducting an analysis and a clinician interpreting the results. The steps are (Roberts 2011):
\n\t\t\t\t\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
However there might not be enough evidence to assign relevant probabilities to candidate solutions or even to structure the clinical problem and find suitable alternative solutions in the first place (see previous step). Thus the process is bound to reform with a new search to fill the present “knowledge gap”. Potentially many iterations of this cycle of data gathering and hypotheses generation may occur until the decision-making clinician has enough clarity to move on through the process. Clinical decision-analysis is hence a fundamental fuel for further research, evidence collection and problem re-evaluation – all for the purpose of finding suitable solutions that will help resolving the clinical situation. CDSS can be programmed in a way that they rearrange themselves for a specific problem, search for relevant evidence and even create new knowledge (Coiera 2003).
\n\t\t\t\t\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
Reasoning in a medical context involves uncertainty to a high extent, combined with constrained resources it therefore leads to increased use of heuristic strategies. Greatest advantage of heuristics is in limiting the extent of purposeful search through data sets and knowledge bases. By reducing redundancy, heuristics have substantial practical value. A significant part of a clinician’s cognitive effort is based on heuristic thinking, the reasoning is inductive with assigned probability for each possible choice. However, the use of heuristics introduces considerable bias in medical reasoning, often resulting in a number of conceptual and procedural errors. These include misconceptions about laws that govern probability, false understanding of manifestation of general rules to a specific patient at the point of care, neglect and false validation of prior probabilities and therapeutic actions. Above all, the cognitive biases that unavoidably affect a human-decision maker are often the hallmark of decision uncertainty (Holyoak 2005).
\n\t\t\t\tIf the designers of CDSSs are to create effective systems which would be successfully implemented into the workflow, providing the clinician with the necessary support of their decision-making abilities, they must be ready to accept the general paths of clinical decision-making process, described above. Efficiently designed and correctly implemented CDSS can elicit extensive positive externalities to the health-workers\' performance and improve patient outcome thus affect the gross quality of healthcare.
\n\t\t\tCDSSs vary very much in their design. The basic principles of structure and design had also changed substantially in the last decade. Various traits of CDSSs are related to or have a direct effect on clinical effectiveness, functionality, error prevention, potential for acceptance in the clinical world, system portability, cost-effectiveness etc. It is thus important to characterize CDSSs in a way to best understand the diversity of CDSS. The knowing of classification, conjunct with an idea of general clinical decision-making processes described above, present a powerful set of basic facts that are useful for CDSSs designers and evaluators.
\n\t\t\tIn this chapter, we will try to characterize CDSS, combining several resources to create a comprehensive classification that capture key elements of CDSS design and function (Coiera 2003; Sim and Berlin 2003; Shortliffe and Cimino 2006; Berner 2007; Greenes 2007). According to Sim and Berlin 2003, the CDSS can be categorized along 5 axes.
\n\t\t\t\n\t\t\t\t\t\t\t
Inpatient setting
Outpatient setting
\n\t\t\t\t\t\t\t
Diagnostic assistance.
Based on the patient’s data and the system’s knowledge base, the CDSS provides likely diagnoses. Diagnostic assistance can be coupled with complex data-retrieval systems, like ECG. It seeks to identify “what is true“ for a specific patient.
\n\t\t\t\tTherapy critiquing and consulting.
This function can for example be incorporated into clinician’s order-entry. It assesses the therapy, looks for inconsistencies, errors, cross-references for drug interactions and prevents prescribing of allergenic drugs. It has been shown that the necessity of a clinician to provide a statement of an appropriate reason, if he is or she is not to follow the recommendations, significantly increases the clinical importance of CDSSs. The CDSS can use protocols and evidence-based guidelines, combined with patient’s facts, acquired from EMR, to provide an optimal treatment plan and help following it. These kinds of CDSSs address the question “what to do“ with a patient and are often combined with recommendations about further diagnostic processing (i.e. which tests to order, X-ray, CT etc.). Such software can generate additional questions as to provide even more specific advice about further therapy (and diagnosis).
\n\t\t\t\tDrug dosing or prescribing.
CDSS have the power to reduce toxic drug levels, reduce medical errors, change prescribing in accordance to guideline recommendations and reduce time to achieving therapeutic control. If connected to EMR, the system can prevent prescription of drugs that cause allergic reactions. Such systems have been widely accepted, since they are well integrated into a routine part of the clinician’s workflow and they provide automated order-entry forms and electronic transmission to pharmacies. Overall prescription of medication is one of the commonest tasks of a physician and also one of the commonest clinical tasks where CDSSs arebeing applied.
\n\t\t\t\tTest selection.
Alerts and reminders.
An expert system that is integrated into a monitoring device or health-care information system (e.g. laboratory information system, EMR) can provide real-time sound, visual or tactile alerts thru various communication tools (e.g. e-mail, SMS, pager). Reminder systems are designed to remind the clinician of crucial tasks that need to be done before a certain event (e.g. fasting before endoscopy, no anticoagulants before abdominal surgery).
\n\t\t\t\tInformation retrieval.
Relevant information retrieval through world wide web or comprehensive knowledge bases.
\n\t\t\t\tImage recognition and interpretation.
Clinical images from CT, MRI, angiograms etc. can nowadays be partially automatically interpreted. More importantly CDSS can function as a mass screening tool, where software flags critical images, which require clinician’s special attention.
\n\t\t\t\tPrevention.
\n\t\t\t\tScreening.
\n\t\t\t\tExpert laboratory system.
\n\t\t\t\tChronic disease management.
\n\t\t\t\tThis axes deals with the sources, quality and customization of the CDSS\'s knowledge and data.
\n\t\t\t\t\n\t\t\t\t\t
It can be derived from high-quality sources (e.g. randomized-controlled trials, systematic reviews, national or professional society guidelines) and/or from participation of clinicians that will eventually use the system.
\n\t\t\t\t\n\t\t\t\t\t
The patient-specific data can be retrieved from computerized order entry, medical instrument (e.g. blood pressure measuring device), EMR or other data repository. The data may also be gathered from a paper chart or a person. In that case data must be entered in the system using a data input intermediary (see bellow). This characteristic affects the likelihood of CDSS adoption in practice to a high extent. It has been shown, that automatic computerized provision of data to the system (e.g. from EMR) is preferred.
\n\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t\t
For various reasons (e.g. funding, epidemiology) it is desirable to use a widely use coding schema, i.e. ICD-10, SNOMED. Obviously the data could also be in plain text.
\n\t\t\t\t\n\t\t\t\t\t
The more CDSS produces patient-specific targeted recommendations, customized to age, gender, concomitant diagnoses etc., more it has a probability of clinical relevance and effectiveness.
\n\t\t\t\t\n\t\t\t\t\t
As stated above, knowledge base ought to be current and constantly up-to-date.
\n\t\t\t\tWe can divide CDSS to knowledge based and non-knowledge based systems.
\n\t\t\t\t\n\t\t\t\t\t
Addressing a suitable decision-making process is probably the most important dimension of CDSS.
\n\t\t\t\t\n\t\t\t\t\t
Rule-based systems. A rule-based system uses different expert knowledge bases in form of expressions that can be evaluated as IF-THEN rules (production rules). Such a system is an example of heuristic approach in which individual logical statements in the form of production rules are obtained by observing human experts, or interviewing and debriefing them, and then combined in an attempt to emulate the reasoning processes of experts. This approach was first used in the MYCIN (Shortliffe 1976), with the goal of choosing appropriate antimicrobial therapy for a patient.
\n\t\t\t\tNeural networks. Artificial neural network is a non-knowledge-based adaptive CDSS that uses machine learning to learn from experiences and recognize patterns in clinical information.
\n\t\t\t\tBayesian network. A typical knowledge-based decision-making system is the Bayesian network (a.k.a belief network or causal probabilistic network) that shows probabilistic relationships between sets of variables – diseases and symptoms, based on conditional probability according to Bayes theorem. It is a network with a explicit requirement, that the relationships be causal. Such a network helps to model the progression of a disease over time and the interaction between diseases; a big road-block however is that medical knowledge sometimes finds it difficult to directly specify what is the effect and what the cause.
\n\t\t\t\tModel based systems. The latest achievement is patient specific modeling (see section 5.2.).
\n\t\t\t\tLogical condition. Logical reasoning makes decisions according to the value of a given variable. The results of a decision-making process are different if the value is within or outside of the set boundaries.
\n\t\t\t\tData mining and machine learning. These methods are based on probabilistic decision-making according to the system’s database. The ideal databases should be large and well constructed, so that they allow precise retrieval of patients similar to a current patient. Analysis of responses of those patients to various treatments is used to decide upon the best treatment for the current patient.
\n\t\t\t\tGenetic algorhytm. As a non-knowledge-based method it uses iterative processes to rearrange itself and provide an optimal solution based on the patient data.
\n\t\t\t\t\n\t\t\t\t\t
Provision of decision support to decisions that have to be made urgently. CDSS should first provide its function to issues with clear clinical priority, according to the principle “treat first what kills first“. This characteristic leads to better patient outcomes and physicians performance.
\n\t\t\t\t\n\t\t\t\t\t
Users are more likely to follow explicit recommendations, providing concrete course of action.
\n\t\t\t\t\n\t\t\t\t\t
The using clinician may be required to provide justification for the way he/she responded to the recommendation provided by the CDSS. This could be done in a form of acknowledgement of recommendation, with a statement of what alternative action was taken and with an explanation for non-compliance.
\n\t\t\tThis axes deals with the delivery of newly produced information to the user.
\n\t\t\t\t\n\t\t\t\t\t
Paper-based, online (via internet or integrated into EMR), via other technology – phone, pager, e-mail etc.
\n\t\t\t\t\n\t\t\t\t\t
The recommendations can be delivered after the decision-maker has requested so or on the other hand it could be delivered without the consent in form of an alert, reminder or optimization request. In the first case the clinician has to make an additional effort, recognize when the advice would be useful, “go to the program“ and enter data to request diagnostic or therapeutic assessment, thus the program is passive.The so-called “push systems“ that automatically provide recommendations may be more effective and substantially more used. They play an active role with providing decision support as a byproduct of data-managing activities (e.g. monitoring, EMR supervision). System decision logic is in a way integrated within a patient\'s database that is already being gathered from various sources and provides results of its decision analysis without an additional effort of the clinician. A valid point to consider here is how to avoid so-called “alarm fatigue“, where the clinician is over-warned to minor discrepancies which are otherwise noted and commonly understood.
\n\t\t\t\t\n\t\t\t\t\t
It is imperative, that the CDSS provides the ability to the decision-maker to exert the recommended actions with ease. For example, the software can, while providing prompts on therapy-critique, also provide direct links to order-entry forms and therapy planning section of EMR. The action of therapy change should be completed within a range of few clicks, for example with checking a mark. Action integration unambiguously adds to wider acceptance and usability of CDSS.
\n\t\t\t\t\n\t\t\t\t\t
It is a function, where the system provides an explanation of its recommendations, through e.g. links to evidence-based articles, books or directly from the knowledge base.
\n\t\t\tCDSS can be seen as a process, however at the point of care it is virtually an intervention of technology, that could also act as an interruption. Systems that are synergistic with the institution\'s workflow are likely to experience higher usage and prove to be more effective in optimizing practitioner\'s performance.
\n\t\t\tDespite the fact, that the computerized CDSSs were continuously in development since the 1970s, their impact on routine clinical practice has not been as strong as expected. The potential benefits of using electronic decision support systems in clinical practice fall into three broad categories (Coiera 2003):
\n\t\t\tImproved patient safety (reduced medication errors and unwanted adverse events, refined ordering of medication and tests);
\n\t\t\tImproved quality of care (increasing clinicians’ time allocated directly to patient care, increased application of clinical pathways and guidelines, accelerate and encourage the use of latest clinical findings, improved clinical documentation and patient satisfaction);
\n\t\t\tImproved efficiency of health-care (reducing costs through faster order processing, reductions in test duplication, decreased adverse events, and changed patterns of drug prescribing, favoring cheaper but equally effective generic brands).
\n\t\t\tDeveloping CDSSs is a challenging process, which may lead to a failure despite our theoretical knowledge about the topic. Understanding the underlying causes, which lead either to success or either to failure, may help to improve the efficiency of CDSS development and deployment in day-to-day practice. Failures can originate from various developmental and implementation phases: failure to technically complete an appropriate system, failure to get the system accepted by the users and failure to integrate the system in the organizational or user environment (Brender, Ammenwerth et al. 2006).
\n\t\t\tThere is an estimation that 45% of computerized medical information systems fail because of user resistance, even though these systems are technologically coherent. Some reasons for such a high percentage of failure may derive from insufficient computer ability, diminished professional autonomy, lack of awareness of long-term benefits of CDSS-use and lack of desire to change the daily workflow (Zheng, Padman et al. 2005). There is also clear evidence that CDSS services are not always used when available, since too numerous systems’ alerts are being overridden or ignored by physicians (Moxey, Robertson et al. 2010).
\n\t\t\tDespite the problems and failures that might accompany CDSSs, these systems have still been proven to improve drug selection and dosing suggestions, reduce serious medication errors by flagging potential drug reactions, drug allergies and identifying duplication of therapy, they enhance the delivery of preventive care services and improve adherence to recommended care standards.
\n\t\t\tRecent studies suggest that there are some CDSS features crucial to success of these systems (Kawamoto, Houlihan et al. 2005; Shortliffe and Cimino 2006; Pearson, Moxey et al. 2009; Moxey, Robertson et al. 2010):
\n\t\t\tCDSS should provide decision support automatically as part of clinicians’ workflow, since systems where clinicians were required to seek out advice manually have not been proven as successful.
\n\t\t\tDecision support should be delivered at the time and location of decision-making. If the clinician has to interrupt the normal pattern of patient care to move to a separate workstation or to follow complex, time-consuming startup procedures it is not likely that such system will be good accepted.
\n\t\t\tSystems that were provided as an integrated component of charting or ordering systems were significantly more likely to succeed than alone standing systems. Generally speaking, the decision-support element should be incorporated into a larger computer system that is already part of the users’ professional routine, thus making decision support a byproduct of practitioners’ ordinary work practices.
\n\t\t\tComputerized systems have been reported to be advantageous over paper-based systems.
\n\t\t\tSystems should provide recommendation rather than just state a patient assessment. For instance, system recommends that the clinician prescribes diuretics for a patient rather just identifying patient being cardiologically decompensated.
\n\t\t\tCDSS should request the clinician to record a reason for not following the systems’ advice (the clinician is asked to justify the decision with a reason, e.g. “The patient refused“).
\n\t\t\tIt should promote clinicians’ action rather than inaction.
\n\t\t\tNo need for additional clinical data entry. Due to clinicians’ effort required for entering new patient data, they tend to avoid this process, which is essential for new decision support. Systems should rather acquire new data automatically (e.g. data retrieval from EMR).
\n\t\t\tThe system should be easy to navigate and use, e.g. with quick access and minimal mouse clicks for desired information.
\n\t\t\tTiming and frequency of prompts are of great importance. For instance if there are too many messages, this might only lead to ignoring all of them and consequently to missing important information. The timing is as well of great importance - the alerts shouldn’t appear at inappropriate times and interrupt the workflow.
\n\t\t\tThe presentation of data or information on CDSSs shouldn’t be too dense or the text to small. Researchers also suggest the use of blinking icons for important tasks or the arrangement of interactions according to their urgency.
\n\t\t\tDecision support results should be provided to both clinicians and patients. Studies have shown beneficial effect of such actions, because they stimulate the clinicians to discuss treatment options with patients, and consequently make the latter feel more involved in their medical treatment.
\n\t\t\tPeriodic feedback about clinician’s compliance with system decision-making.
\n\t\t\tWhat these features have in common is that they all make it easier for clinicians to implement the CDSS into their workflow, thus making it easier to use. An effective CDSS must minimize the effort to receive and act on system recommendations. Clinicians found it also very practical if the CDSS would back up its decision-making with linking it to other knowledge resources across the intranet or Internet. In their opinion the safety and drug interaction alerts were the most helpful feature. Above all the organizational factors, such as computer availability at the point of care and technical perfection of CDSS hardware and software are crucial to implementation (Moxey, Robertson et al. 2010).
\n\t\t\t\n\t\t\t\tKawamoto 2005 suggests that the effectiveness of CDSS remains mainly unchanged when system recommendations are stated more strongly and when the evidence supporting these prompts is expanded and includes institution-specific data. Similarly, the effectiveness and functionality remains unaltered when recommendations are made more specific. Interestingly the CDSSs didn’t achieve wanted results when local clinicians were recruited into the system development process nor when bibliographic citations were provided to support the system made recommendations (Kawamoto, Houlihan et al. 2005).
\n\t\t\tTo sum up, when developing CDSSs, there are factors beyond software and content that must be taken into consideration. Fundamental issues include availability and accessibility of hardware, sufficient technical support and training in use of the system, the level of system integration into clinical workflow and the relevance and timeliness of the clinical messages provided.
\n\t\tThere have been multiple attempts through history to construct a computer or program, which would assist clinicians with their decisions concerning diagnosis and therapy. Ledley and Lusted published the first article evolving around this idea in 1959. The first really functional CDSS didn’t appear until the 1970s. We will review the following historical systems: Leeds abdominal pain, MYCIN, HELP and Internist-1.
\n\t\t\t\tF. T. de Dombal and his co-workers at University of Leeds developed Leeds abdominal pain. It used Bayesian reasoning on basis of surgical and pathological diagnoses. These pieces of information were gathered from thousands of patients and put into systems’ database. The Leeds abdominal pain system used sensitivity, specificity and disease-prevalence data for various signs, symptoms and test results. With help of Bayes’ theorem it calculated the probability of seven possible diagnoses resulting in acute abdominal pain: appendicitis, diverticulitis, perforated ulcer, cholecystitis, small-bowel obstruction, pancreatitis, and nonspecific abdominal pain. The system assumed that each patient with abdominal pain had one of these seven conditions, thus selected the most likely diagnose on the basis of recorded observations. Evaluation of the system was done by de Dombal et al. in 1972. It showed that the clinicians’ diagnoses were correct in only 65 to 80 percent of the 304 cases, whereas the program’s diagnoses were correct in 91.8 percent of cases. Surprisingly, the system has never achieved similar results of diagnostic accuracy in practice outside the Leeds University. The most likely reason for that is the variation of data that clinicians entered into the system for acquiring correct diagnoses (de Dombal, Leaper et al. 1972).
\n\t\t\t\tMYCIN was a consultation system that emphasized appropriate management of patients who had infections rather than just finding their diagnosis. The developers of this system formed production rules (IF-THEN rules), on basis of current knowledge about infectious diseases. The MYCIN program determined which rules to use and how to chain them together in order to make decisions about a specific case. System developers could update the system\'s knowledge structure rapidly by removing, altering, or adding rules, without reprogramming or restructuring other parts of the system (Shortliffe 1976).
\n\t\t\t\tThe HELP system is actually an integrated hospital information system with the ability to generate alerts when data abnormalities in the patient record are noted. It can output data either automatically, in form of printed reports, or it can display specific information, if so requested. Furthermore, the system has an event-driven mechanism for generation of specialized warnings, alerts and reports (Burke, Classen et al. 1991).
\n\t\t\t\tInternist-I was an experimental CDSS designed by Pople and Myers at the University of Pittsburg in 1974. It was a rule-based expert system capable of making multiple, complex diagnoses in internal medicine based on patient observations. The Internist-I was using a tree-structured database that linked symptoms with diseases. The evaluation of the system revealed that it was not sufficiently reliable for clinical application. Nevertheless, the most valuable product of the system was its medical knowledge base. This was used as a basis for successor systems including CADUCEUS and Quick Medical Reference (QMR), a commercialized diagnostic CDSS for internists (Miller, Pople et al. 1982).
\n\t\t\t\n\t\t\t\t\t
The Athena decision support system was deployed in 2002 as a tool to implement guidelines for hypertension. It encourages blood pressure control and issues recommendations about a suitable choice of therapy, concordant with latest guidelines. It also considers co-morbidities of the specific patient in question. ATHENA DSS has an easily changeable knowledge base that specifies criteria for eligibility, risk stratification, set blood pressure margins, it includes relevant co-morbid states and guideline-recommendation, specific for patients with present co-morbidities. The knowledge base also comprises of preferences for certain drugs within antihypertensive drug groups according to the latest evidence. New pieces of evidence are constantly changing protocols of best hypertension management; ATHENA is thus designed to be accessible to clinicians for knowledge base-customization and to custom local interpretations of guidelines according to the local population structure and other factors. The system was designed to be independently integrated into a variety of EMR-systems, and is thus interchangeable and adaptable for various health information-systems. The effectiveness, accuracy and success of implementation has been researched and reviewed on many occasions (Goldstein, Coleman et al. 2004; Lai,Goldstein et al. 2004). Such systems as ATHENA can help with supporting general efforts of national and worldwide health care organizations in effective implementation and stricter following of issued guidelines in various fields of medicine.
\n\t\t\t\tIn 2006 ATHENA DSS for opioid therapy was developed according to specific guidelines for the management of opioid therapy for chronic pain (Trafton, Martins et al. 2010).
\n\t\t\t\tThis system uses EON architecture from the Stanford University. EON is a knowledge-based system that aids physicians with care of patients treated according to protocols and guidelines. It is constructed from set of software components that are embedded into a wider health information system, which uses patient-specific data. These software components are designed in such a way to be compiled together in various ways, mixed to create different decision-support functionalities. There are several components that are interrelated:
\n\t\t\t\tKnowledge base encodes descriptions of clinical protocols; it is a source of evidence-based data for all other software components of EON.
\n\t\t\t\tProblem solvers: They determine the right protocol for the patient, i.e. solve a task of placing the patient within the right therapy protocol, by addressing the knowledge base and incorporating patient’s attributes (e.g. blood pressure measures and co-morbidities).
\n\t\t\t\tEligibility-determination component addresses the same knowledge base to match the factors in a patient with a certain protocol in order to ascertain if he/she is eligible for such a treatment,
\n\t\t\t\tDatabase mediator is a conductor between all the components in EON and the database that stores patients’ information. More sophisticated mediators already extract the relevant data and make relevant connections before presenting it to an EON problem-solver (Nguyen, Shahar et al. 1997).
\n\t\t\t\t\n\t\t\t\t\t
Isabel is a web-based diagnosis decision support system that was created in 2001 by physicians. It offers diagnosis decision support at the point of care. The system is eligible for all aged patients, from neonates to geriatrics. Its database covers major specialties like Internal Medicine, Surgery, Gynecology & Obstetrics, Pediatrics, Geriatrics, Oncology, Toxicology and Bioterrorism. Isabel produces an instant list of likely diagnoses for a given set of clinical features (symptoms, signs, results of tests and investigations etc), followed by suggesting the administration of suitable drugs. This is executed by reconciling (i.e. pattern-matching technology) patient data sets with data sets as described in established medical literature. The system allows clinicians to follow their assumptions about differential diagnoses; it hence restricts searches to specific body systems, relatively to diagnoses in question. The system is interfaced with EMR, which allows it to extract existing diagnoses and other patient-specific data. Furthermore it contains a feature to help clinicians answer their questions with up to date knowledge from textbooks and journals.
\n\t\t\t\tIsabel uses Autonomy’s natural language processing software as a search tool. The pattern of the clinical features entered is concept-matched with kernels of knowledge; then the best-matched kernels of knowledge (diagnoses) are returned for consideration. Autonomy’s technology is based on advanced pattern-matching techniques (non-linear adaptive digital signal processing) rooted in the theories of Bayesian Inference and Claude Shannon\'s Principles of Information (Autonomy 2009). These enable identification of patterns that naturally occur in text, based on the usage and frequency of words or terms that correspond to specific concepts. Based on the predominance of one pattern over another within a piece of information, this technology enables computers to recognize when a particular document in question is about the searched subject. In this way, it extracts a document\'s digital essence and enables various operations to be automatically performed on that text.
\n\t\t\t\tIsabel has been extensively validated and been shown to enhance clinician’s cognitive skills and thereby improves patient safety and the quality of patient care (Ramnarayan, Tomlinson et al. 2004; OpenClinical 2006).
\n\t\t\t\tLISA is a CDSS that consists of two main components. The first is a centralized Oracle database, holding all patient information about drug schedules, blood and toxicity results, doses prescribed etc. The database is accessible by health professionals from different sectors and locations. The second component represents a web-based decision support module, which is using the PROforma guideline development technology to provide advice about dose adjustments in treatment of acute childhood lymphoblastic leukemia. LISA is primarily concerned with providing support in the maintenance illness-period during which drug dose decisions have to be continually monitored and adjusted, as responses to these drugs vary significantly from patient to patient. Decision support is considered useful in this period, since many dose-errors have occurred in practice (Hurt, Fox et al. 2003). In order to give the patient an appropriate dosage of chemotherapeutics, the system uses PRO
Evaluational studies of LISA have concluded that the system is likely to be accepted by clinicians. Furthermore, the authors are predicting that the usage of LISA could lead to a decrease in non-compliance with the treatment protocol (Bury, Hurt et al. 2004).
\n\t\t\t\t\n\t\t\t\t\t
One of the promising novel concepts useful in CDSSs is Patient-Specific Modeling (PSM), which uses individualized computational models of human pathophysiology to model the dynamics of a wide variety of tissues and organs. It is not a CDSS per-se, we could rather think of it as functionality that adds-on and re-invents the process of clinical decision-making. Integrated into CDSSs it has a potential to even further improve diagnosis and optimize clinical treatment by predicting outcomes of therapies and surgical interventions. PSM is being pursued in well-funded projects, like the Virtual Physiological Human initiative (Viceconti, Clapworthy et al. 2007) and the International Physiome Project (Bassingthwaighte 2000).
\n\t\t\t\tMajor advantage of PSM is that in contrast to regular diagnostic practices, which are based on averaged clinical trials, it provides tailored treatment and optimizes the individual therapy. While the training and experience of the physician prove to be the most valuable when deciding for the best treatment from an available range, this decision-making process often does not take into account all the data potentially available. Decision-making that bases on the results of simulations, which use models derived from patient-specific data, however, sometimes deal with basically immeasurable physical properties of tissues, e.g. tissue stress in the vessel-wall of a distending abdominal aneurysm (Doyle, Callanan et al. 2009). The results of such simulations enable judgment on effectiveness of a range of potential treatments before they are actually administered, preventing the patient from experiencing unneeded or ineffective treatments. We can think of such theoretical predictive data as descriptors that are used to very accurately asses values of outcome measures in a process of clinical decision-making
\n\t\t\t\tPSM has been studied and reviewed in modeling of blood vessels, bones, brain, skeletal muscle, heart and in modeling of the behavior of various tumors (Neal and Kerckhoffs 2010).
\n\t\t\t\tThere are several basic elements, which are common to all fields of PSM in support of clinical decision-making. Data are obtained from the patient’s medical record (EMR), e.g. from a virology genotypic assay or an angiography scan. The data is then used to construct a computational model, which is used to perform a complex workflow of simulations of a proposed protocol of treatment. Molecular dynamics simulations of drugs interacting with a range of viral proteins for example, provide results that are then interpreted to assess the efficacy of the treatment in question. This gives the physician an afore unimaginable ability to choose a treatment based on prior knowledge of how will that specific patient respond to it on a molecular-physiologic basis (Sadiq, Mazzeo et al. 2008).
\n\t\t\t\tSuch patient-specific simulations require access to comprehensive patient data and an appropriate infrastructure for performing very large numbers of complex and demanding simulations. For this manner heterogeneous supercomputing grid technologies are used, which address, in real time, the outcome of many diverse emergency situations, such as the development and impact of hurricanes and earthquakes (Manos, S. et al. 2008). In the biomedical technology, high-performance computation has been used as a research capacity to investigate the interactions in many tissues with regard to biomolecular function and its interference due to disease, and all that in real time. Such real-time large-scale computation, meet the needs of the clinical environment, thus making “ultra patient-specific“ clinical decision-support with PSM increasingly achievable.
\n\t\t\t\tDespite the attention that PSM has gotten in recent time, the evaluation of its predictive capability has not yet been tested on a large scale and is thus yet to become a standard in clinical care (Neal and Kerckhoffs 2010).
\n\t\t\tWith the possibility of employing CDSS in telemedicine, we take a closer look at a computerized model for the evaluation of a patient’s health status in nursing care (Šušteršič et al., 2009). Holistic evaluation of a patient\'s health status is essential for solid decision making regarding the proper patient treatment. Our solution is based on a hierarchical multi-attribute decision model (HMADM) (Turban et al., 2004; Triantaphyllou, 2010). With this approach the practical efficiency of the Henderson’s theoretical model of basic living activities (BLA) increases (Henderson & Nite, 1997).
\n\t\t\tLet us first present our solution from the structural point of view as described in chapter 2. With regard to the context axes, it deals with not only inpatients and outpatients but also with community nursing. It assists a nurse in practically all phases of the nursing process, including setting nursing diagnoses and nursing interventions. Its role also includes prevention, screening and chronic disease management. Special emphasis is on alerts and reminders.
\n\t\t\tThe knowledge and data source axes are based on the theoretical BLA model. Data are collected directly from the patients or patients’ records. The described CDSS is built upon widely used coding schemas such as ICNP and NANDA.
\n\t\t\tDecision making process is based on a combination of HMADM and expert systems. The knowledge base consists of a tree of criteria and rule based utility functions for every aggregated node in the tree. This way individual patient data are aggregated in an overall assessment of a patient’s health status.
\n\t\t\tConcerning information delivery, the system is request-based with a special emphasis on the explanation of the evaluation results. Thus, the transparency of the nursing process as a workflow is enhanced.
\n\t\t\tThe proposed HMADM can be applied both when analysing patient’s health status and when explaining the results of the evaluation. Despite the holistic nature of the BLA approach, these models are not being sufficiently used in clinical practice (Šušteršič et al., 2002; Ozbolt & Bakken, 2006). A possible reason for limited use is the fact that a large number of parameters are used to describe a patient’s health status. This means that it is difficult to gather information on all the parameters. Furthermore, the process of drawing a conclusion becomes very complex. However, the HMADM methodology helps to address these problems. (Potter & Perry, 2002; Gordon, 2009)
\n\t\t\tIncreasing the operability of the BLA model can be achieved by understanding the model as a HMADM for evaluating patient’s health. The model, which has been based on BLA (Šušteršič et al., 1999; Bohanec et al., 2000), is a comprehensive evaluation tool for the nursing care support process. This part of the patient’s record becomes hierarchically structured and gains additional transparency, which facilitates the identification of nursing problems, setting of nursing diagnoses and planning of the appropriate nursing care.
\n\t\t\tPatient’s changes in health status on the basis of the defined indicators are monitored at chosen time intervals. In terms of community nursing, where the model was tested, such intervals coincided with health visits or successive sessions using the tele-nursing approach. The model offers a helping hand to nurses as it reduces the possibility of overlooking problems that could otherwise lead to unwanted healthcare events.
\n\t\t\tHierarchical multi-attribute decision models are primarily developed for option evaluation: each option, in this case a patient, is described by values of basic attributes and is evaluated according to the model. The final outcome is an overall evaluation for each option (patient). Furthermore, an evaluation result of the option makes it possible to investigate how the result was obtained. It also provides an insight into what specific attributes can be managed to improve the outcome. (Pöyhönen & Hämäläinen, 2001; Tsoukias, 2008)
\n\t\t\tThe majority of current multi-attribute decision methods are aimed at the development of quantitative decision models (Triantaphyllou, 2010). In such models, all the attributes are continuous and utility functions are typically defined in terms of the attributes’ weight, e.g. as a weighted-sum of lower-level attributes. In practice, however, the difficulty of understanding the underlying data behind the numerical results proves to be a common problem. The relationships between the attributes are linear, although the nature of the attributes often requires non-linear interdependence. In other words, different weights can be assigned to a single attribute depending on its relative importance. In contrast, Decision Expert (DEX) methodology (Bohanec & Rajkovič 1990), which is used in our approach, deals with discrete attributes, usually represented by words rather than numbers. The corresponding utility functions are represented by decision rules. Each rule represents one point or several equi-utility points of function values. The utility (aggregation) functions used in the DEX model are therefore not represented by formulae, such as weighted-sum, but are presented as tables of function values, i.e. decision rules (Rajkovič et al., 1988). This way, a HMADM can be built on non-linear discrete utility functions. It can be compared with the relative weights approach, where the weights depend on parameter values. If a parameter value changes, its relative importance (weight) can also be changed if required. By using the DEX interface, expressing and understanding such utility functions as sets of decision rules becomes suitable for being used in practice.
\n\t\t\tA HMADM model, based on the BLA model, was developed by an expert team of nurses for the evaluation of patient’s health and was tested in two health centres in Slovenia. This model uses indicators, which are measurable BLA criteria for describing a patient’s health condition, as basic attributes. In the criteria tree, the BLA are hierarchically organized and, therefore, interconnected. Utility functions are presented as tables of decision rules. In accordance with those rules, the values and definitions of the higher level criteria are defined by the combination of the values and definitions of the lower level criteria, which enter the model as their predecessors. As a result, a comprehensive evaluation of a patient’s health is obtained at the top of the criteria tree. The hierarchical structure of a comprehensive evaluation of the BLA is shown in Table 1, which represents a DEX output in tree form, including criteria descriptions. Each attribute is measured on a five-point scale: “problem to a very high degree” (vhd), “problem to a high degree” (hd), “problem to some degree” (sd), “problem to a lesser degree” (ld) and “no problem” (no).
\n\t\t\t\tCOMPREHENSIVE EVALUATION | \n\t\t\t\t\t\t\tEvaluation of all basic living activities | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | \n\t\t\t\t\t\t |
├─PHYSICAL BLA | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | BLA concerning physical patient’s condition | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ ├─OEBt | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Oxygenation, Elimination, Body temp. | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ │ ├─Oxygenation | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Mechanical inhalation and | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ │ │ | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | exhalation of air, circulation | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ │ ├─ELIMINATION | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Movement & elimination of waste | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ │ └─BODY TEMPERATURE | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | The temperature of the body | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ ├─NPaS | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Nutrition and hydration, | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ │ │ | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Physical activity, Sleep, Rest | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ │ ├─NUTRITION | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Nutrition and hydration | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ │ ├─PHYSICAL ACTIV. | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Ability of body movement | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ │ └─SLEEP | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Sleep, restoration and rest | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ └─AdHD | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Avoidance of danger, hygiene and tidiness,dressing | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ ├─AVOIDANCE of DANG. | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Physical, psychology and social security | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ ├─HYGIENE | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Tidiness and hygiene of body | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ └─DRESSING | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Dressing and undressing | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
└─PSYCHOSOCIAL BLA | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | BLA concerning psycho-social patient’s condition | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
├─RRb | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Relationship with people, | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
│ | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | communication, religious beliefs | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
└─PltE | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Purposeful activit., Leisure time and Health educ. | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
├─PURPOSEFUL ACTIV. | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Harmonisation of work and recreation | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
├─LEISURE TIME | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Useful use of time | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
└─EDUCATION | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t | Health education | \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t |
DEX printout of hierarchical structure of a comprehensive evaluation of BLA
The comprehensive evaluation model has 20 attributes comprising of 13 basic and 7 aggregate attributes. These correspond to the main attributes of the BLA criteria, covering items relating both to the patient’s physical and psychosocial condition. They include: oxygenation, elimination, body temperature (OEBt); nutrition and hydration, physical activity, sleep and rest (NPaS); avoidance of danger from the environment, hygiene and tidiness, dressing (AdHD); relationships with people, communication, psychological and social needs, including religious beliefs (RRb); and purposeful activity, leisure time, health education (PLtE). The model also includes seven utility functions, one for each aggregate criterion, including the root of the tree which represents the final evaluation result. Each utility function is defined by a table of decision rules that determine the value of each aggregate attribute on the basis of the mutual dependence on lower-level attributes (immediate predecessor).
\n\t\t\t\tHere is an example of a decision rule on how the value of aggregate attribute is defined: if OEBt is assessed as a problem ‘to some degree’, NPaS as a problem ‘to some degree’ or worse and AdHD as being on the boundary between ‘to a high degree’ and ‘to some degree’, the overall patient’s evaluation of physical BLA is evaluated as ‘to a high degree’.
\n\t\t\t\tThe utility functions (sets of decision rules) must be semantically appropriate, i.e. they must express correct nursing knowledge, so verification and validation play important roles. Two steps were included in the present model to achieve this: in the first, a group of chosen experts agreed on utility functions, taking into account existing knowledge from the literature and their experiences and, in the second, nurses validated the knowledge by using decision rules during their practical work.
\n\t\t\tTesting of the HMADM took place in the community health care environment. The model was used during the entire treatment with a special emphasis on home visits. There were two main objectives of the testing: (i) to validate the nursing knowledge embedded in the model, especially with regard to the decision rules; and (ii) to test the actual operability of the model in practice, i.e. by testing during home visits.
\n\t\t\t\tDuring practical use of the model, transparent decision rules encouraged nurses to critically assess and to validate the nursing knowledge expressed by the rules. Nurses provided comments regarding the appropriateness of the proposed decision rules and the results of the evaluation of the BLA model. The extent to which the HMADM encouraged assessment of the interdependencies between various criteria was also observed.
\n\t\t\t\tTesting of the model was monitored during successive home visits. Each nurse used the model to evaluate their patients’ health status on regular daily visits. Each nurse carried out between five and seven home visits daily, which were of a preventive and curative nature. At each visit, special emphasis was placed on analysing the patient’s health with the set of BLA indicators.
\n\t\t\t\tDifferent patient groups were included, ranging from newborns to the elderly, either due to health promotion, prevention or recovery. Observed were different health problems such as nutrition problems, chronic diseases, wound management etc. An example of a ‘comprehensive evaluation of BLA’ of a newborn baby (NB) is presented in Table 2, where evaluations from three successive visits (NB1, NB2 and NB3) are listed. The root of the tree, which represents the final overall evaluation, shows how the baby’s health condition or their need for nursing care changed from one visit to another. Considerable improvement of the baby‘s health can be observed. On the first visit the ‘Comprehensive evaluation’ was regarded as a problem to a ‘very high degree’, on the second visit as a problem to a ‘high degree’ and, on the third visit, just as a problem to ‘some degree’. Table 2 breaks down the comprehensive evaluation result and shows that, at the first visit (NB1), there was a problem to a ‘very high degree’ for hygiene and education, and a problem to ‘some degree’ with elimination, sleep, avoidance of danger, RRb and leisure time. A nurse can easily see all of the existing problems and their actual values (degrees of problem) together with their propagation through the tree of attributes, including interrelationships, up to their influence on the overall evaluation. Such transparency improves understanding of the reasons for changes in the patient’s health status and encourages nurses’ critical thinking in terms of further actions that they need to take.
\n\t\t\t\t\n\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t
Evaluation of a newborn from three successive evaluations
Changes in health indicators can also be followed graphically and Fig. 1 presents the changes during the three visits in the evaluation of physical BLA overall and its four improved sub-attributes: elimination, physical activity, avoidance of danger and hygiene; the condition remained unchanged for sleep. The nurses themselves could choose the indicators, which were then presented as a time series and this customization of the data eliminated the need for further data analysis. Changes in the values of the indicators from one visit to another can also be viewed as a helpful tool in the quality assurance processes.
\n\t\t\t\tNurses who took part in the testing prepared their reports and structured interviews were carried out with each nurse. The reports and interviews served as the basis for a strengths, weaknesses, opportunities and threats (SWOT) analysis. The nurses indentified three main strengths: (i) the model supports holistic understanding necessary for identification of the nature and level of nursing problems; (ii) the computerized hierarchical structure enriches nursing documentation; and (iii) the possibilities of overlooking something important are reduced. Among the weaknesses, they emphasized the increased amount of work that was involved in using the model because of the need for consistently following a methodical work process. Opportunities suggested by the nurses were the development of electronic documentation and the consistent holistic evaluation of a patient’s health status in the framework of the nurse’s competencies. It could contribute to improved patient safety and also to the safety of members of the health team. On the basis of indicators and their values some adverse events can be predicted. If an adverse event occurs, we can explain the reasons and help determine personal responsibility. As the main threat, they listed their apprehension about computer-supported models being perceived as replacing nurses’ creative thinking and work.
\n\t\t\t\tTranscript of changes of the selected criteria of a newborn’s Physical BLA during three visits
The proposed CDSS uses the BLA model for assessing patients’ health. It is built on multi-attribute decision-making theory in order to assess a patient’s observed condition. The outcome is a a computer-calculated comprehensive evaluation based on the model. During clinical testing of the model in practice, transparency appeared to increase along the whole process and not only, as it was initially expected, during the phase of assessing patient health. This implies that patient data can be followed upward through the tree of criteria to the final estimate and an explanation can be provided of how the estimate was obtained and from where it originated. This way a contribution is made to an efficient evaluation that provides a holistic and transparent overview of the patient’s condition. The structured approach based on the BLA tree assists nurses in keeping up with a large data set and their inter-relationships. This is especially vital when relatively small changes in some indicators may in combination with other indicators result in serious problems for the patient. A better understanding of the outcomes reduces the possibility of overlooking clinically important information. Together with appropriate nursing documentation, this computerized model can contribute to a higher quality of nursing and increased patient safety, as well as increased safety for health team members.
\n\t\t\tIt is clear that systems supporting clinical decision-making of doctors, nurses and other health-workers have an immense potential to benefit in their performance, provision of quality care and, what we strive for – better patient outcomes. In common sense, one can take better care of patients if one has superb knowledge about the clinical matters in question. For example, it could be said that with more information and knowledge a clinician has a better chance of solving a clinical problem in favor of the patient, the hospital and himself. The problem is that nowadays global knowledge about a topic is often overwhelming for a clinician to process at the point of care or in urgent situations. CDSSs incorporate patient-specific data and an applicable, well-structured and current knowledge base or evidence-based guidelines, thus serving the clinician with enhancing his/her clinical decision-making process. Such support of basic cognitive processes involved in medical thinking to some extent relieves the clinician and provides him with new, better-formed and possibly superior methods to take best care of the ill.
\n\t\t\tMany characteristics of CDSSs are related to clinical effectiveness, functionality, error prevention, potential for acceptance in the clinical world, system portability, cost-effectiveness etc., it is therefore important to fully understand the construction and different modalities of CDSS.
\n\t\t\tThe most successful CDSSs deal with therapy critiquing and consulting and/or drug dosing or prescribing. Latest CDSSs use EMR to provide data for analysis, and they provide the ability to the decision-maker to exert the recommended actions with ease, being completely integrated into the information system. Developers of CDSSs should thus be aware that there are factors beyond software and content that must be taken into consideration. Fundamental issues include the level of system integration into clinical workflow and the relevance and timeliness of the clinical messages provided, availability and accessibility of hardware and sufficient technical support and training in use of the system. Reasons for difficulties in implementing CDSS into everyday clinical practice come mainly from programmers’ insufficient understanding of medical reasoning and decision analyses. Such systems to some extent pose a threat to diminished clinicians’ professional autonomy. Above all there is generally still a lack of awareness of long-term benefits of CDSS-use and lack of desire to change the daily workflow.
\n\t\t\tTo encourage better health-processes, better individual patient care and better population health through CDSSs development, they need to be under constant improvement and their evolvement controlled from an appointed group of experts. To this end the American Medical Informatics Association developed a road map for action on CDSSs, regarding development, implementation and use. This road map comprises of three pillars, with their own subsets, which should bring sense into future evolvement and successful implementation of CDSSs (Lyman, Cohn et al. 2010).
\n\t\t\tBest knowledge available when needed;
\n\t\t\tRepresent clinical knowledge and CDSS interventions in standardized formats.
\n\t\t\tThere are multiple and most of the time very diverse types of formats used within CDSSs. The patient-specific data and thereafter computerized decision making is usually not exchangeable. This limits free interchange of patients between different institutions on national and international level. It thereby consequently limits the dispersion CDSSs and merits that global usage would bring.
\n\t\t\tCollect, organize and distribute clinical knowledge and CDSS interventions in a way that users easily find suitable material and incorporate it in their own information systems.
\n\t\t\tHigh adoption and effective use
\n\t\t\tAddress policy, legal and financial barriers
\n\t\t\tThe health care policy of e.g. European Union should support CDSSs implementation and development. One could expect that as EU directed the electronification of health care it should also direct further evolvement and implementation of CDSSs in everyday clinical practice. Review on research done in this field show multiple beneficial effects of using CDSS, resulting in better patient outcomes, enhanced health-care performance and consequently greater cost effectiveness of electronic health systems.
\n\t\t\tWith implementing CDSSs in everyday practice, we are obliged to consider the legal consequences of its usage. The obvious conflict is if the decision of CDSS is in discordance with the clinician’s opinion. For example, we should consider, what would mean if the clinician wouldn’t agree with CDSSs recommendations, which would in common medical sense, be wrong, but the clinicians’ actions would anyway result in medical error or even death. How much weight would bear a decision of CDSS? How could we prove that the outcome would be different or better by following CDSS’s decision-making? On the other hand CDSSs can impose a regulatory role in following the current medical guidelines. In a way CDSS can prevent a clinician in making medical errors by alerting about e.g. EU-accepted guidelines. CDSS can be viewed as a tool to track clinician’s actions. Such information, if comprehensive and detailed, could be of great importance in a court of law.
\n\t\t\tImprove the practice of deployment
\n\t\t\tImprove the ease of usage
\n\t\t\tContinuous improvement of knowledge and CDSS methods
\n\t\t\tSystematically capturing, organizing and examining existing CDSS deployments (e.g. http://www.openclinical.org)
\n\t\t\tAdvance care-guiding knowledge by using the data readily available in EMR, thus improving clinical knowledge and health management.
\n\t\t\tNot only that EMR is time saving and basically essential for health information-system (and thus a CDSS) to function successfully and be integrated into a workflow, it is also a source of data for forming new knowledge. EMR can easily provide data for clinical research, e.g. statistical analyses of patient outcomes, based on their illnesses and clinician’s actions. The results of such analyses could be automatically invested into improving the power of CDSS’s decision-making.
\n\t\t\tDespite all challenges in CDSS development and implementation, these systems have shown to be of great use. Further research and education in this area is therefore essential in order to utilize CDSSs to a higher extent in everyday clinical reality. The implications and positive externalities of CDSSs may well prove to be some of the strongest factors that will influence the health-care development in years to come.
\n\t\tFish farming is an animal production sector that followed, in the past years, various dynamic paths according to the region considered. For instance, between 1995 and 2015, this sector displayed a strong increase at global scale with a production rising from 14.9 to 51.3 Mt. (+242%), whereas only a slight increase was observed within the European Union countries: from 490,000 to 660,000 tons (+34%). At national level, fish production has decreased from 65,500 tons in 1995 to 44,500 tons in 2005 (−32%) in France, despite its expansion in other countries like Norway. This fact illustrates that the development of this sector depends strongly on territorial contexts. Despite projections indicating the strong increase of aquaculture at global scale up to 2050, much higher than any other animal production sectors, except for poultry production [1, 2], some territories are facing several obstacles. These obstacles include, among others, (i) competition with other economic sectors (fisheries, tourism, agriculture, production of potable water, etc.), for access to land and water resources, (ii) an economical context of free exchange that often results in strong competition with imported products coming from countries with much lower production costs, (iii) policies (environmental and social protection, food safety, etc.) most often perceived as very binding, and (iv) a degraded image of rearing systems and farming products for which sustainability is frequently questioned by societies in developed countries, particularly concerning quality of products, respect of animal welfare, and environmental impacts. All these issues could hamper the development of aquaculture in some developed countries, such as France. In this context, it is hard to conceive that fish farming could increase significantly in those regions. Nevertheless, these territories are heterogeneous and often display a strong historical, cultural (e.g., culinary traditions), and landscape (mountainous or coastal regions, ponds, wetlands, etc.) diversity that results in numerous microterritories with their specific consumption of fish or more exactly very typical products or dishes. This is particularly true for Europe and France. For instance, one might cite the consumption of smoked eel in the Netherlands [3], frying of cyprinids (roach, rudd) in the Valley of Moselle (Luxemburg), tench in the region of Extremadura in Spain, fried carps in the Sundgau in Alsace in France, meager in the southeast French Mediterranean Sea, or Eurasian perch in the countries around the Alps. These small markets rely on a close link between local populations, the history of the territory, and the presence of a specific landscape (e.g., country of ponds) or particular ecosystems (lakes) and the animal species inhabiting these regions. This tight link between consumers and species is obviously the case for the market of Eurasian perch in the Alps region, where consumers often require the presence of the fish skin to clearly observe the alternation of dark and light bands, typical of this species [4]. These are key advantages for this territory that could allow the development of a diversified and resilient aquaculture based on the diversification of the production and the domestication of new fish species, corresponding to a development model that we can call “mosaic aquaculture.” This is in this global context associated with this vision that the domestication of Eurasian perch started in the early 1990s, 25 years ago. The understanding of the initial motivations and the process of domestication realized over this period require first considering the specificities of inland European aquaculture and associated territories.
\nIn Europe (European Union), inland aquaculture only represents 25.3% of the total production [5]. Two main distinct economic sectors exist, salmoniculture (farming of salmonids, chiefly monoculture of rainbow trout (
The initial choice of Eurasian perch resulted from several points that were taken into account locally, like at the Lorraine territory scale in France. First, at national level, there was at that time the mutual motivation by several stakeholders (producers, policymakers, and developing agencies) to promote and diversify freshwater aquaculture with different incentives, even though the human consumption market was targeted (Table 1). In Lorraine, this dynamism first resulted in one part in the structuring of the inter-profession with the establishment of the Inland Aquaculture Lorraine Sector (Filière Lorraine d’Aquaculture Continentale) in 1987 and on the other part the inception of a new specific university diploma in inland aquaculture, the “Ingénieur-Technologue” DI-T [6, 7, 8]. Besides, carnivorous fishes, such as Eurasian perch, pikeperch
Species | \nTerritories | \nInitial will | \nCurrent production in France | \n
---|---|---|---|
Black bass | \nSouth-West | \nAngling, human consumption | \nNegligible | \n
Siberian sturgeon | \nAquitaine | \nTo preserve another sturgeon species ( | \n17 farms, third global producer of caviar | \n
Eurasian perch | \nLorraine, Rhône-Alpes | \nHuman consumption | \n100 tons, three perch farms | \n
Wels | \nCentre, Languedoc | \nHuman consumption | \nNegligible | \n
Trials of diversification and domestication of new fish species in inland aquaculture in metropolitan France during the last decades of the twentieth century.
Countries | \nProduction/exploited ecosystems | \nValorization | \n
---|---|---|
Germany | \nFisheries (large lakes, rivers, Baltic Sea) | \nAngling, exportation, weak human consumption | \n
Austria | \nFisheries (Constance Lake) | \nExportation, human consumption | \n
Belgium | \nFisheries in rivers, polyculture in ponds | \nAngling | \n
Bulgaria | \nFisheries in rivers or in reservoirs | \nAngling, human consumption | \n
Denmark | \nFisheries in lakes or estuaries | \nAngling, exportation | \n
Finland | \nFisheries in Baltic Sea and inland waters | \nAngling, strong human consumption | \n
France | \nFisheries in lakes and rivers | \nAngling, strong human consumption (East) | \n
Great Britain | \nFisheries in lakes and rivers | \nAngling | \n
Hungary | \nFisheries in lakes and rivers | \nAngling | \n
Ireland | \nLough Neagh | \nExportation | \n
Luxemburg | \nFisheries in rivers | \nAngling, weakly consumed | \n
Norway | \nFisheries in inland waters of East, South, and North-East | \nAngling, exportation, human consumption | \n
Netherlands | \nFisheries in IJsselmeer lakes and inland waters | \nAngling, weak human consumption | \n
Baltic countries | \nFisheries in lakes | \nExportation | \n
Poland | \nFisheries in inland waters (Swinoujscie region) | \nAngling, exportation | \n
Czech Republic and Slovakia | \nFisheries in the Danube River and other rivers | \nAngling, human consumption | \n
Romania | \nFisheries in ponds, in the Danube River, Razelm Lake | \nAngling, human consumption | \n
Serbia and Macedonia | \nFisheries in the Danube River and lakes (Dojran Lake) | \nHuman consumption | \n
Sweden | \nFisheries in the Baltic Sea | \nAngling, exportation, human consumption | \n
Switzerland | \nFisheries in lake | \nAngling, strong human consumption | \n
Interest for Eurasian perch according to European countries, survey realized in 1993 [9].
Summing up, the domestication of Eurasian perch appeared as a good compromise for several reasons: (1) a diversification of aquaculture production targeting the human consumption market by valuing a native species known by consumers and benefiting from a good image and an established market niche and (2) the development of a new activity that did not harm other traditional activities of the sector (no competition). Initially, this project of diversification aimed at developing a complementary activity for pond fish farmers. Besides, linking to the survey realized [9], a possible competition with capture fisheries coming from Eastern and Central Europe as well as Scandinavia was highlighted; yet, surveyed persons stated that the capture levels were highly variable from one year to another, product quality (filleting yield) also strongly varied (effect of reproductive cycle), and supply period of market was stopped during the spawning season in spring. Consequently, all these facts confirmed the possibilities to develop an aquaculture of Eurasian perch targeting a regular production of fresh fillets with a constant and high quality.
\nA the end of the 1980s and beginning of the 1990s, an in-depth analysis of the available literature on the biology of Eurasian perch and a North American close species, the yellow perch
During the 1990s, researches were undertaken to first better know the life cycle of the species in local aquatic ecosystems, mainly in the Mirgenbach reservoir and Lindre ponds (Moselle, France), and second to determine the potential of this species at different stages (larval rearing, on-growing). The choice of the Mirgenbach was linked to the fact that this reservoir presents heated waters due to the nuclear power plant of Cattenom and could potentially present thermic conditions more favorable for the growth of perch, in the perspective of a future economic development. These field studies allowed describing the feeding regime, growth (relation size-weight), composition of the main tissues (muscles, gonads, liver, viscera), as well as the reproductive cycle [27, 41, 42, 43, 44]. These data constituted the frame of reference and brought the basis for future experimentations, such as the control of the reproductive cycle. In parallel to these descriptive studies, first trials of acclimatization were realized using perch sampled at different development stages in natural conditions (e.g., egg ribbons mainly from the Leman Lake, INRA Thonon-les-Bains, Haute-Savoie, France), polyculture ponds (young perch of 4–20 g for Lorraine fish farm ponds), or rivers (eggs ribbons from Meuse). The acclimatization of young perch, either juveniles or sexually mature individuals, with diverse features from one year to another, was closely linked to the will to value stocks of fish often very abundant during fall and spring pond fisheries and displaying a low market value. Based on the works performed on the yellow perch [32, 34, 36], several weaning protocols were tested using feeds or diverse raw materials (beef liver, frozen plankton, dried or hydrated formulated feeds) [45]. Because of (i) very high mortality rate (40–60% in 2 months) linked to food refusal, development of pathologies caused by
Timeline displaying the key phases of the domestication of Eurasian perch with from one hand the main knowledge acquired and the decisive decision taken (above the bar) and from the other hand the major events that occurred (below the bar) over the period 1990–2018.
Once the rearing system selected (intensive monoculture in RAS for the production of fillet for human consumption), diverse researches were performed in order to control the life cycle of the species in indoor conditions. They include the control of the reproductive cycle, the development of larval rearing protocols, the determination of nutritional needs, the optimization of growth performances, the control of quality of products, and first trials of genetic improvement. These researches were funded by both national (mainly in Belgium and France) and international, chiefly thanks to the European Union (FAIR-CT96-1572 1996-1998, FAIR-CT98-9241 1998-1999, Σ! 2321 ACRAPEP/ANVAR A0011134L 2001-2004, COOP-CT-2004-512629-PERCATECH 2004-2006) programs.
\nEven though the market for the perch fillet remains seasonal in the traditional consumption market (March–October), the development of an intensive monoculture in RAS required a complete control of the reproductive cycle in order to obtain out-of-season spawning and not only rely on the single annual reproduction occurring in spring [41, 42, 43, 56]. A first research axis focused on the environmental control of the reproductive cycle. A preliminary test demonstrated the possibility of controlling the reproductive cycle by manipulating both water temperature and duration of photoperiod [57]. Thereafter, these researches allowed disentangling the respective roles of water temperature variations and duration of photophase by distinguishing the different phases of a reproductive cycle: induction, vitellogenesis, and final steps of the cycle [58, 59, 60, 61, 62, 63, 64, 65, 66]. All these works allowed developing a reliable protocol for the induction of out-of-season spawning close to 100% [67]. This program is now routinely applied in farm conditions; it allowed the realization of 2–12 reproductive cycles per year with different batches of breeders managed in delayed conditions. If the temperature variations and the duration of photoperiod drive the timing of the successive steps of the reproductive cycle (determining factors), other factors can modulate the quality of reproductive performances observed. For example, the feeding strategy is very important, and thus the nutritional needs of breeders were specified [68, 69]. In fact, numerous rearing factors, including environmental, nutritional, and populational, can act on breeders and influence their reproductive performances; multifactorial approaches must be used to optimize rearing conditions and secure performances [70, 71].
\nComplementary to the control of reproductive cycle for the induction of out-of-season spawning, additional protocols based on hormonal injection were developed to synchronize spawning during the reproductive season [72, 73, 74, 75, 76, 77]. They were based on previous works performed on the yellow perch [78, 79, 80]. The application of hormonal injections is now facilitated by the use of a classification method of oocyte stage maturation in preovulatory period [81]. At last, reliable protocols for collecting gametes (spermatozoa, oocytes) and artificial reproduction are also now available [82].
\nInitially, trials of larval rearing were performed with spawning collected in various aquatic areas. Like for on-growing trials, several ways were initially prospected to promote the production of weaned juveniles: (1) an extensive production in small ponds with an
The very strong impact of cannibalism within the first weeks of rearing was rapidly confirmed during the first commercial production [53]. Up to now, the strategy adopted by fish farmers to reduce cannibalism relies on frequent sorting (each week or 2 weeks) to maintain homogeneous batches during the nursery period and early weeks of on-growing. At that level, the results obtained by Mandiki et al. [99] suggested that they are natural populations less aggressive than others are, when they are placed in rearing conditions. Consequently it could be interesting to evaluate the intraspecific variability of wild populations (search for more docile populations). Concerning the problems of the inflation of the swim bladder and developmental anomalies often linked to the first point, they are mainly related to larval rearing conditions [100]. An improvement of rearing conditions associated with a high level of prophylaxis allowed increasing inflation rates and reduced malformation rates. In order to avoid the on-growing of individuals without swim bladder, protocols of sorting, based on practices realized in marine fish farming, were developed [101, 102]. Today, perch farms with well-conceived and seriously managed hatchery-nursery produce regular batches of 0.5 up to 1 million of weaned juveniles. However, developmental anomalies remain regularly observed in farms [103]. It is important to specify that the publication of a developmental table for the embryo-larvae corresponding to a normal development constitutes a major tool to identify the causes of common developmental anomalies) [104].
\nOnce fry were available, trials on pre-on-growing and on-growing were realized in order to determine from one part the optimal conditions of growth and on the other part the potential of this species. It was first demonstrated that this species has a diurnal feeding activity [105]; the application of photoperiod with a long photophase stimulates growth and inhibits gonadal development [106]. First rearing trials had also demonstrated the gregarious behavior of this species (schooling behavior) and its ability to feed on pellets [46]. At this period, feeds for rainbow trout or sea bass were distributed to perch; feed conversion rates of 1.0–1.5 were registered according to the ration rate applied [49, 106, 107, 108]. High survival rates were also obtained (>80%).
\nOnce these favorable prerequisites were established (gregarious behavior, sufficient survival, acceptability of artificial feeds, correct alimentary conversion rate, etc.), more dedicated researches were realized on the effects of both major abiotic and biotic factors on growth. Thus, it was demonstrated that the optimal temperature for growth was 22–24°C [107]. Thereafter, complementary works allowed specifying the effects of the rearing environment (tank wall color, light intensity, manipulations) on the ingested feed and growth [109, 110]. The effects of rearing conditions on the physiological state of fish were also studied; perch appeared as very sensitive to both poor conditions and manipulations [111, 112]. At the feeding level, ration table for maintenance and optimal and maximal growth according to physiological stages were determined [107, 108, 113, 114]. Then, nutritional needs were progressively determined to promote the emergence of a feed for percids once the volume of production would be large enough. Thus, the nutritional requirements in proteins, lipids, and some additives, such as oxidative as ethoxyquin, were specified [89, 115, 116, 117, 118]. These studies allowed defining that a feed for perch should contain 43–50% of proteins, 13–18% of lipids, and 10–15% of glucids [119].
\nThe domestication of species for the human consumption market requires knowing and controlling the quality of products (whole fish, fillet). Thus, very early, once the first zootechnical trials were completed, the chemical composition of the tissue of perch, and notably muscle, was analyzed [41, 120]. One major goal was the production of constant quality fillet to consumers, similar to the wild fillet coming from the lake. Researches were started from one part to understand the natural variability of organoleptic properties of the perch fillet according to the origin of captures and, on the other part, to identify the determinants of this quality. Importantly, the quality of a product is a vague and complex notion that depends on nutritional, technological, sensorial, and sanitary features. Thus, features of perch coming from different regions (Geneva Lake, Rhine estuary) were compared among themselves and to perch obtained from RAS [121, 122]. It was found that first the quality of products was highly variable according to the natural environment studied and second that farming factors (feeds, rearing densities, etc.) strongly impacted the properties of farmed perch [123, 124]. In fact, the control of the quality of products (flesh or whole fish), over the course of domestication, is multifactorial [125, 126].
\nThe Eurasian perch displays a sexual dimorphism of growth in favor of females [107, 108]; thus, the production of monosex female populations has rapidly appeared as a solution to reduce growth heterogeneity and increase growth performances. Hence, protocols (hormonal treatment with 17α-methyltestosterone) were developed for the production of homogametic males or neomales (XX) [127], with a sperm quality similar to heterogametic males [128]. Once produced and mature, those neomales were breeded with normal females (XX) allowing the production of 100% females, for which growth improvements were observed after 7 months of rearing in RAS at 23°C [129]. In a complementary study, trials of production of 100% female populations were also realized by gynogenesis using spermatozoa inactivated by UV radiation [130]. However, due to the low survival rates as well as insufficient growth performances, this method is rarely used [129].
\nA second path, triploidization, was also studied in order to produce sterile animals. This path also appeared as very important because Eurasian perch is a species that can start a reproductive cycle before reaching market size. It is possible to capture in natural habitats (ponds) sexually mature females and males as such low weights as 10–20 g, even lower for males. As for other species reared in fish farming (salmonids), protocols based on thermal or pressure chocks were also developed to produce triploid perch [131].
\nWith the development of perch farms (7–8 farms localized in Germany, France, Ireland, and Switzerland) and the increase of production in RAS (estimated between 500 and 800 tons per year), first thinking on the necessity to develop selective breeding programs emerged, mainly to improve growth performances and decrease production costs. Yet, up to now, no true selective breeding programs exist, even though basic genetic knowledge was acquired to develop them. Studies have notably allowed to characterize the genetic variability of wild perch, very often used as founding populations of current farmed stocks [132, 133] and stocks of domesticated breeders currently present in perch farms [134]. These studies have demonstrated that the available stocks of domesticated perch in farms were (i) sufficiently genetically variable to allow developing selective genetic programs (lack of consanguinity) and (ii) often genetically distant from the origin populations (Alpine lakes) presumably assumed by fish farmers.
\nThe domestication of a species requires the onset of periods of exchanges between all stakeholders of the sector (Figure 1), notably to allow transfer of expertise and co-elaboration of projects based on the identification of priorities and major bottlenecks. Concerning Eurasian perch, very rapidly, the few research laboratories implied in this species cooperated and organized scientific seminars at different scales to allow sharing new knowledge. The meetings organized at the transatlantic level (Canada, USA, and Europe) aimed first at sharing works performed on Eurasian and yellow perch. Some of these events (Namur, 2008; Nancy, 2014) had for main objective exchanges between the socioeconomic stakeholders of the sector (fish farmers, designer of fish farms, traders in aquatic products, etc.). Progressively, knowledge was compiled in more and more comprehensive book [135, 136]. Obviously, this diffusion of knowledge and co-construction also occurred at local, regional, and national scales. In France, for instance, an informal group of exchanges, entitled “National group of pond carnivorous fish,” often met in the beginning of the 1990s to discuss experience on various species (Wels, pikeperch, black-bass, and perch) that were the subject of diversification [137, 138, 139, 140]. At the regional level, in Lorraine, the “ Filière Lorraine d’Aquaculture Continentale (FLAC)” supports diverse zootechnical trials and, therefore, actively contributes to the emergence of perch farms on this territory. Later a similar initiative was taken in other regions from other countries, like in Ireland [141].
\nThe domestication of Eurasian perch was initially based on local issues (niche market, development of activities and jobs in rural environments). This domestication occurred in a few main steps: (1) socioeconomic analysis of the market, (2) first zootechnical trials and choice of the major rearing system (RAS), and (3) acquisition of in-depth knowledge on the successive stages of the production cycle (control of the reproductive cycle and reproduction, control of the larval rearing, on-growing, and quality of products) (Figure 1). It is important to highlight that the first two steps strongly considered the knowledge previously acquired on a close species, the yellow perch. Today, the Eurasian perch is considered at the level 4 of domestication, which means that the entire life cycle is closed in captivity without any wild inputs but no selective breeding programs is applied [142].
\nEven though the first experimental trials were initiated at the beginning of the 1990s, the first perch farm (SARL Lucas Perches) created within the European Union was located in 2002 as a pilot enterprise. Importantly in Switzerland, a perch farm, Percitech, was created much earlier in 1994. About 20 years later, numerous projects were launched, some with very high expectations (e.g., FjordFresh Holding S/A in Estonia), in numerous European countries; 10 of these enterprises truly developed a commercial activity. Today, most perch farms pursue their activities; only few, mainly in Ireland (country where perch is not consumed), have stopped their activity. The investors that initially believed in this species were not issued from the aquaculture sector and discovered it. Sometimes, it corresponds to industrials that succeeded in other sectors and wants to diversify their activities. This initial distance from the aquaculture sector constitutes one of the reasons of the slow development of perciculture. Learning requires time. Without doubt, the domestication of Eurasian perch was and remained a particular human adventure, where the link between the species and humans is visible at different levels and various forms.
\nIn terms of perspective, one can expect that this young sector will pursue its development first based on current farms, whose economic viability remains to be demonstrated and second in link with the emergence of new projects and expansion of the market toward new consumers. This new development could imply the production of both pikeperch and perch within the same farms. To support this development, it is imperative to reduce production costs, high in RAS, and secure current stocks. The decrease of cost production will require in priority the onset of selective breeding programs and genetic improvements, a standardization and rationalization of rearing protocols (e.g., percid feeds, ration tables, etc.) and a reduction of investment levels for the development of new perch farms. For some, the development of a monoculture of perch in ponds could be the solution because it will allow a strong decrease in production cost. On the security side, it is important to (i) better know pathologies associated with this species, notably virus, among which some might represent a major risk for percids [143] and (ii) specify the effects of the domestication process on rearing performances of this species. As any other domesticated species, biological responses and performances of perch are modified by the domesticating environment specific to the rearing system chosen and associated rearing practices. Thus, preliminary results indicated that reproductive performances [144, 145] and its sensitivity to stress and immune system [146, 147, 148, 149, 150] depend on farm conditions. In the future, the domesticating context (Figure 2) could strongly vary according to local environment, which could lead fish farmer to choose different rearing systems and to target different markets. Once this main choice realized (context and domesticating direction fixed), secondary choices will define the trajectory of domestication that will result in physiological stage capture in nature, of the dynamic of transition (progressive or sharp) and cultural practices used, practices that could evolve over time with different dynamics. This complexity is reinforced by the fact that a population engaged in a specific domesticating context could change into another context because of a modification in the project, as was the case for perch reared in polyculture ponds, then weaned, and grown in cages or RAS (Figure 2). This diversity of directions and domesticating trajectories should lead to different evolutions (behavior, stress physiology, reproduction, etc.) variable from a context to another. These evolutions could even lead fish farmers to reconsider the initial choice of founding populations, given the enormous genetic diversity available in wild populations [4].
\nDiagram explaining the different domestication frameworks and pressures encountered by Eurasian perch during current farming trials (F: Framework, T: Trajectory, P: Path).
IntechOpen books are indexed by the following abstracting and indexing services:
",metaTitle:"Indexing and Abstracting",metaDescription:"IntechOpen was built by scientists, for scientists. We understand the community we serve, but to bring an even better service to the table for IntechOpen Authors and Academic Editors, we partnered with the leading companies and associations in the industry and beyond.",metaKeywords:null,canonicalURL:"/page/indexing-and-abstracting",contentRaw:'[{"type":"htmlEditorComponent","content":"Clarivate Web Of Science - Book Citation Index
\\n\\nCroatian Library (digital NSK)
\\n\\nOCLC (Online Computer Library Center) - WorldCat® Digital Collection Gateway
\\n\\n\\n\\n
\\n"}]'},components:[{type:"htmlEditorComponent",content:'
Clarivate Web Of Science - Book Citation Index
\n\nCroatian Library (digital NSK)
\n\nOCLC (Online Computer Library Center) - WorldCat® Digital Collection Gateway
\n\n\n\n
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5820},{group:"region",caption:"Middle and South America",value:2,count:5289},{group:"region",caption:"Africa",value:3,count:1761},{group:"region",caption:"Asia",value:4,count:10546},{group:"region",caption:"Australia and Oceania",value:5,count:909},{group:"region",caption:"Europe",value:6,count:15933}],offset:12,limit:12,total:119318},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{},books:[{type:"book",id:"8969",title:"Deserts and Desertification",subtitle:null,isOpenForSubmission:!0,hash:"4df95c7f295de7f6003e635d9a309fe9",slug:null,bookSignature:"Dr. Yajuan Zhu, Dr. Qinghong Luo and Dr. Yuguo Liu",coverURL:"https://cdn.intechopen.com/books/images_new/8969.jpg",editedByType:null,editors:[{id:"180427",title:"Dr.",name:"Yajuan",surname:"Zhu",slug:"yajuan-zhu",fullName:"Yajuan Zhu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9667",title:"Neuroimmunology",subtitle:null,isOpenForSubmission:!0,hash:"9cf0e8203ce088c0b84add014fd8d382",slug:null,bookSignature:"Prof. Robert Weissert",coverURL:"https://cdn.intechopen.com/books/images_new/9667.jpg",editedByType:null,editors:[{id:"79343",title:"Prof.",name:"Robert",surname:"Weissert",slug:"robert-weissert",fullName:"Robert Weissert"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9816",title:"Idiopathic Pulmonary Fibrosis",subtitle:null,isOpenForSubmission:!0,hash:"365bb9762ba33db2d07e677690af1772",slug:null,bookSignature:"Dr. Salim Surani and Dr. Venkat Rajasurya",coverURL:"https://cdn.intechopen.com/books/images_new/9816.jpg",editedByType:null,editors:[{id:"15654",title:"Dr.",name:"Salim",surname:"Surani",slug:"salim-surani",fullName:"Salim Surani"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10218",title:"Flagellar Motility in Cells",subtitle:null,isOpenForSubmission:!0,hash:"5fcc15570365a82d9f2c4816f4e0ee2e",slug:null,bookSignature:"Prof. Yusuf Bozkurt",coverURL:"https://cdn.intechopen.com/books/images_new/10218.jpg",editedByType:null,editors:[{id:"90846",title:"Prof.",name:"Yusuf",surname:"Bozkurt",slug:"yusuf-bozkurt",fullName:"Yusuf Bozkurt"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10223",title:"Obesity and Health",subtitle:null,isOpenForSubmission:!0,hash:"c202a2b74cd9a2c44b1c385f103ac65d",slug:null,bookSignature:"Dr. Venketeshwer Rao and Dr. Leticia Rao",coverURL:"https://cdn.intechopen.com/books/images_new/10223.jpg",editedByType:null,editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10231",title:"Proton Therapy",subtitle:null,isOpenForSubmission:!0,hash:"f4a9009287953c8d1d89f0fa9b7597b0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10231.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10343",title:"Ocular Hypertension",subtitle:null,isOpenForSubmission:!0,hash:"0ff71cc7e0d9f394f41162c0c825588a",slug:null,bookSignature:"Prof. Michele Lanza",coverURL:"https://cdn.intechopen.com/books/images_new/10343.jpg",editedByType:null,editors:[{id:"240088",title:"Prof.",name:"Michele",surname:"Lanza",slug:"michele-lanza",fullName:"Michele Lanza"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10370",title:"Advances in Fundamental and Applied Research on Spatial Audio",subtitle:null,isOpenForSubmission:!0,hash:"f16232a481c08a05cc191ac64cf2c69e",slug:null,bookSignature:"Dr. Brian FG Katz and Dr. Piotr Majdak",coverURL:"https://cdn.intechopen.com/books/images_new/10370.jpg",editedByType:null,editors:[{id:"278731",title:"Dr.",name:"Brian FG",surname:"Katz",slug:"brian-fg-katz",fullName:"Brian FG Katz"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10504",title:"Crystallization",subtitle:null,isOpenForSubmission:!0,hash:"3478d05926950f475f4ad2825d340963",slug:null,bookSignature:"Dr. Youssef Ben Smida and Dr. Riadh Marzouki",coverURL:"https://cdn.intechopen.com/books/images_new/10504.jpg",editedByType:null,editors:[{id:"311698",title:"Dr.",name:"Youssef",surname:"Ben Smida",slug:"youssef-ben-smida",fullName:"Youssef Ben Smida"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10519",title:"Middleware Architecture",subtitle:null,isOpenForSubmission:!0,hash:"c326d436ae0f4c508849d2336dbdfb48",slug:null,bookSignature:"Dr. Mehdia Ajana El Khaddar",coverURL:"https://cdn.intechopen.com/books/images_new/10519.jpg",editedByType:null,editors:[{id:"26677",title:"Dr.",name:"Mehdia",surname:"Ajana El Khaddar",slug:"mehdia-ajana-el-khaddar",fullName:"Mehdia Ajana El Khaddar"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10557",title:"Elaeis guineensis",subtitle:null,isOpenForSubmission:!0,hash:"79500ab1930271876b4e0575e2ed3966",slug:null,bookSignature:"Dr. Hesam Kamyab",coverURL:"https://cdn.intechopen.com/books/images_new/10557.jpg",editedByType:null,editors:[{id:"225957",title:"Dr.",name:"Hesam",surname:"Kamyab",slug:"hesam-kamyab",fullName:"Hesam Kamyab"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:28},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:8},{group:"topic",caption:"Business, Management and Economics",value:7,count:3},{group:"topic",caption:"Chemistry",value:8,count:11},{group:"topic",caption:"Computer and Information Science",value:9,count:10},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:10},{group:"topic",caption:"Engineering",value:11,count:25},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:4},{group:"topic",caption:"Materials Science",value:14,count:7},{group:"topic",caption:"Mathematics",value:15,count:3},{group:"topic",caption:"Medicine",value:16,count:48},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:4},{group:"topic",caption:"Psychology",value:21,count:5},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:220},popularBooks:{featuredBooks:[{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10201",title:"Post-Transition Metals",subtitle:null,isOpenForSubmission:!1,hash:"cc7f53ff5269916e3ce29f65a51a87ae",slug:"post-transition-metals",bookSignature:"Mohammed Muzibur Rahman, Abdullah Mohammed Asiri, Anish Khan, Inamuddin and Thamer Tabbakh",coverURL:"https://cdn.intechopen.com/books/images_new/10201.jpg",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",middleName:null,surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8148",title:"Investment Strategies in Emerging New Trends in Finance",subtitle:null,isOpenForSubmission:!1,hash:"3b714d96a68d2acdfbd7b50aba6504ca",slug:"investment-strategies-in-emerging-new-trends-in-finance",bookSignature:"Reza Gharoie Ahangar and Asma Salman",coverURL:"https://cdn.intechopen.com/books/images_new/8148.jpg",editors:[{id:"91081",title:"Dr.",name:"Reza",middleName:null,surname:"Gharoie Ahangar",slug:"reza-gharoie-ahangar",fullName:"Reza Gharoie Ahangar"}],equalEditorOne:{id:"206443",title:"Prof.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman",profilePictureURL:"https://mts.intechopen.com/storage/users/206443/images/system/206443.png",biography:"Professor Asma Salman is a blockchain developer and Professor of Finance at the American University in the Emirates, UAE. An Honorary Global Advisor at the Global Academy of Finance and Management, USA, she completed her MBA in Finance and Accounting and earned a Ph.D. in Finance from an AACSB member, AMBA accredited, School of Management at Harbin Institute of Technology, China. Her research credentials include a one-year residency at the Brunel Business School, Brunel University, UK. Prof. Salman also served as the Dubai Cohort supervisor for DBA students under the Nottingham Business School, UK, for seven years and is currently a Ph.D. supervisor at the University of Northampton, UK, where she is a visiting fellow. She also served on the Board of Etihad Airlines during 2019–2020. One of her recent articles on “Bitcoin and Blockchain” gained wide visibility and she is an active speaker on Fintech, blockchain, and crypto events around the GCC. She holds various professional certifications including Chartered Fintech Professional (USA), Certified Financial Manager (USA), Women in Leadership and Management in Higher Education, (UK), and Taxation GCC VAT Compliance, (UK). She recently won an award for “Blockchain Trainer of the Year” from Berkeley Middle East. Other recognitions include the Women Leadership Impact Award by H.E First Lady of Armenia, Research Excellence Award, and the Global Inspirational Women Leadership Award by H.H Sheikh Juma Bin Maktoum Juma Al Maktoum.",institutionString:"American University in the Emirates",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"American University in the Emirates",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9959",title:"Biomedical Signal and Image Processing",subtitle:null,isOpenForSubmission:!1,hash:"22b87a09bd6df065d78c175235d367c8",slug:"biomedical-signal-and-image-processing",bookSignature:"Yongxia Zhou",coverURL:"https://cdn.intechopen.com/books/images_new/9959.jpg",editors:[{id:"259308",title:"Dr.",name:"Yongxia",middleName:null,surname:"Zhou",slug:"yongxia-zhou",fullName:"Yongxia Zhou"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9685",title:"Agroecosystems",subtitle:"Very Complex Environmental Systems",isOpenForSubmission:!1,hash:"c44f7b43a9f9610c243dc32300d37df6",slug:"agroecosystems-very-complex-environmental-systems",bookSignature:"Marcelo L. Larramendy and Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9685.jpg",editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9161",title:"Frailty in the Elderly",subtitle:"Understanding and Managing Complexity",isOpenForSubmission:!1,hash:"a4f0f2fade8fb8ba35c405f5ad31a823",slug:"frailty-in-the-elderly-understanding-and-managing-complexity",bookSignature:"Sara Palermo",coverURL:"https://cdn.intechopen.com/books/images_new/9161.jpg",editors:[{id:"233998",title:"Ph.D.",name:"Sara",middleName:null,surname:"Palermo",slug:"sara-palermo",fullName:"Sara Palermo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5327},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10201",title:"Post-Transition Metals",subtitle:null,isOpenForSubmission:!1,hash:"cc7f53ff5269916e3ce29f65a51a87ae",slug:"post-transition-metals",bookSignature:"Mohammed Muzibur Rahman, Abdullah Mohammed Asiri, Anish Khan, Inamuddin and Thamer Tabbakh",coverURL:"https://cdn.intechopen.com/books/images_new/10201.jpg",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",middleName:null,surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8148",title:"Investment Strategies in Emerging New Trends in Finance",subtitle:null,isOpenForSubmission:!1,hash:"3b714d96a68d2acdfbd7b50aba6504ca",slug:"investment-strategies-in-emerging-new-trends-in-finance",bookSignature:"Reza Gharoie Ahangar and Asma Salman",coverURL:"https://cdn.intechopen.com/books/images_new/8148.jpg",editors:[{id:"91081",title:"Dr.",name:"Reza",middleName:null,surname:"Gharoie Ahangar",slug:"reza-gharoie-ahangar",fullName:"Reza Gharoie Ahangar"}],equalEditorOne:{id:"206443",title:"Prof.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman",profilePictureURL:"https://mts.intechopen.com/storage/users/206443/images/system/206443.png",biography:"Professor Asma Salman is a blockchain developer and Professor of Finance at the American University in the Emirates, UAE. An Honorary Global Advisor at the Global Academy of Finance and Management, USA, she completed her MBA in Finance and Accounting and earned a Ph.D. in Finance from an AACSB member, AMBA accredited, School of Management at Harbin Institute of Technology, China. Her research credentials include a one-year residency at the Brunel Business School, Brunel University, UK. Prof. Salman also served as the Dubai Cohort supervisor for DBA students under the Nottingham Business School, UK, for seven years and is currently a Ph.D. supervisor at the University of Northampton, UK, where she is a visiting fellow. She also served on the Board of Etihad Airlines during 2019–2020. One of her recent articles on “Bitcoin and Blockchain” gained wide visibility and she is an active speaker on Fintech, blockchain, and crypto events around the GCC. She holds various professional certifications including Chartered Fintech Professional (USA), Certified Financial Manager (USA), Women in Leadership and Management in Higher Education, (UK), and Taxation GCC VAT Compliance, (UK). She recently won an award for “Blockchain Trainer of the Year” from Berkeley Middle East. Other recognitions include the Women Leadership Impact Award by H.E First Lady of Armenia, Research Excellence Award, and the Global Inspirational Women Leadership Award by H.H Sheikh Juma Bin Maktoum Juma Al Maktoum.",institutionString:"American University in the Emirates",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"American University in the Emirates",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9959",title:"Biomedical Signal and Image Processing",subtitle:null,isOpenForSubmission:!1,hash:"22b87a09bd6df065d78c175235d367c8",slug:"biomedical-signal-and-image-processing",bookSignature:"Yongxia Zhou",coverURL:"https://cdn.intechopen.com/books/images_new/9959.jpg",editors:[{id:"259308",title:"Dr.",name:"Yongxia",middleName:null,surname:"Zhou",slug:"yongxia-zhou",fullName:"Yongxia Zhou"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9685",title:"Agroecosystems",subtitle:"Very Complex Environmental Systems",isOpenForSubmission:!1,hash:"c44f7b43a9f9610c243dc32300d37df6",slug:"agroecosystems-very-complex-environmental-systems",bookSignature:"Marcelo L. Larramendy and Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9685.jpg",editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8564",title:"Cell Interaction",subtitle:"Molecular and Immunological Basis for Disease Management",isOpenForSubmission:!1,hash:"98d7f080d80524285f091e72a8e92a6d",slug:"cell-interaction-molecular-and-immunological-basis-for-disease-management",bookSignature:"Bhawana Singh",coverURL:"https://cdn.intechopen.com/books/images_new/8564.jpg",editors:[{id:"315192",title:"Dr.",name:"Bhawana",middleName:null,surname:"Singh",slug:"bhawana-singh",fullName:"Bhawana Singh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9515",title:"Update in Geriatrics",subtitle:null,isOpenForSubmission:!1,hash:"913e16c0ae977474b283bbd4269564c8",slug:"update-in-geriatrics",bookSignature:"Somchai Amornyotin",coverURL:"https://cdn.intechopen.com/books/images_new/9515.jpg",editedByType:"Edited by",editors:[{id:"185484",title:"Prof.",name:"Somchai",middleName:null,surname:"Amornyotin",slug:"somchai-amornyotin",fullName:"Somchai Amornyotin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9021",title:"Novel Perspectives of Stem Cell Manufacturing and Therapies",subtitle:null,isOpenForSubmission:!1,hash:"522c6db871783d2a11c17b83f1fd4e18",slug:"novel-perspectives-of-stem-cell-manufacturing-and-therapies",bookSignature:"Diana Kitala and Ana Colette Maurício",coverURL:"https://cdn.intechopen.com/books/images_new/9021.jpg",editedByType:"Edited by",editors:[{id:"203598",title:"Ph.D.",name:"Diana",middleName:null,surname:"Kitala",slug:"diana-kitala",fullName:"Diana Kitala"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7030",title:"Satellite Systems",subtitle:"Design, Modeling, Simulation and Analysis",isOpenForSubmission:!1,hash:"b9db6d2645ef248ceb1b33ea75f38e88",slug:"satellite-systems-design-modeling-simulation-and-analysis",bookSignature:"Tien Nguyen",coverURL:"https://cdn.intechopen.com/books/images_new/7030.jpg",editedByType:"Edited by",editors:[{id:"210657",title:"Dr.",name:"Tien M.",middleName:"Manh",surname:"Nguyen",slug:"tien-m.-nguyen",fullName:"Tien M. Nguyen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10413",title:"A Collection of Papers on Chaos Theory and Its Applications",subtitle:null,isOpenForSubmission:!1,hash:"900b71b164948830fec3d6254b7881f7",slug:"a-collection-of-papers-on-chaos-theory-and-its-applications",bookSignature:"Paul Bracken and Dimo I. Uzunov",coverURL:"https://cdn.intechopen.com/books/images_new/10413.jpg",editedByType:"Edited by",editors:[{id:"92883",title:"Prof.",name:"Paul",middleName:null,surname:"Bracken",slug:"paul-bracken",fullName:"Paul Bracken"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9154",title:"Spinal Deformities in Adolescents, Adults and Older Adults",subtitle:null,isOpenForSubmission:!1,hash:"313f1dffa803b60a14ff1e6966e93d91",slug:"spinal-deformities-in-adolescents-adults-and-older-adults",bookSignature:"Josette Bettany-Saltikov and Gokulakannan Kandasamy",coverURL:"https://cdn.intechopen.com/books/images_new/9154.jpg",editedByType:"Edited by",editors:[{id:"94802",title:"Dr.",name:"Josette",middleName:null,surname:"Bettany-Saltikov",slug:"josette-bettany-saltikov",fullName:"Josette Bettany-Saltikov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8148",title:"Investment Strategies in Emerging New Trends in Finance",subtitle:null,isOpenForSubmission:!1,hash:"3b714d96a68d2acdfbd7b50aba6504ca",slug:"investment-strategies-in-emerging-new-trends-in-finance",bookSignature:"Reza Gharoie Ahangar and Asma Salman",coverURL:"https://cdn.intechopen.com/books/images_new/8148.jpg",editedByType:"Edited by",editors:[{id:"91081",title:"Dr.",name:"Reza",middleName:null,surname:"Gharoie Ahangar",slug:"reza-gharoie-ahangar",fullName:"Reza Gharoie Ahangar"}],equalEditorOne:{id:"206443",title:"Prof.",name:"Asma",middleName:null,surname:"Salman",slug:"asma-salman",fullName:"Asma Salman",profilePictureURL:"https://mts.intechopen.com/storage/users/206443/images/system/206443.png",biography:"Professor Asma Salman is a blockchain developer and Professor of Finance at the American University in the Emirates, UAE. An Honorary Global Advisor at the Global Academy of Finance and Management, USA, she completed her MBA in Finance and Accounting and earned a Ph.D. in Finance from an AACSB member, AMBA accredited, School of Management at Harbin Institute of Technology, China. Her research credentials include a one-year residency at the Brunel Business School, Brunel University, UK. Prof. Salman also served as the Dubai Cohort supervisor for DBA students under the Nottingham Business School, UK, for seven years and is currently a Ph.D. supervisor at the University of Northampton, UK, where she is a visiting fellow. She also served on the Board of Etihad Airlines during 2019–2020. One of her recent articles on “Bitcoin and Blockchain” gained wide visibility and she is an active speaker on Fintech, blockchain, and crypto events around the GCC. She holds various professional certifications including Chartered Fintech Professional (USA), Certified Financial Manager (USA), Women in Leadership and Management in Higher Education, (UK), and Taxation GCC VAT Compliance, (UK). She recently won an award for “Blockchain Trainer of the Year” from Berkeley Middle East. Other recognitions include the Women Leadership Impact Award by H.E First Lady of Armenia, Research Excellence Award, and the Global Inspirational Women Leadership Award by H.H Sheikh Juma Bin Maktoum Juma Al Maktoum.",institutionString:"American University in the Emirates",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"American University in the Emirates",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10201",title:"Post-Transition Metals",subtitle:null,isOpenForSubmission:!1,hash:"cc7f53ff5269916e3ce29f65a51a87ae",slug:"post-transition-metals",bookSignature:"Mohammed Muzibur Rahman, Abdullah Mohammed Asiri, Anish Khan, Inamuddin and Thamer Tabbakh",coverURL:"https://cdn.intechopen.com/books/images_new/10201.jpg",editedByType:"Edited by",editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",middleName:null,surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9959",title:"Biomedical Signal and Image Processing",subtitle:null,isOpenForSubmission:!1,hash:"22b87a09bd6df065d78c175235d367c8",slug:"biomedical-signal-and-image-processing",bookSignature:"Yongxia Zhou",coverURL:"https://cdn.intechopen.com/books/images_new/9959.jpg",editedByType:"Edited by",editors:[{id:"259308",title:"Dr.",name:"Yongxia",middleName:null,surname:"Zhou",slug:"yongxia-zhou",fullName:"Yongxia Zhou"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editedByType:"Edited by",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8760",title:"Structure Topology and Symplectic Geometry",subtitle:null,isOpenForSubmission:!1,hash:"8974840985ec3652492c83e20233bf02",slug:"structure-topology-and-symplectic-geometry",bookSignature:"Kamal Shah and Min Lei",coverURL:"https://cdn.intechopen.com/books/images_new/8760.jpg",editedByType:"Edited by",editors:[{id:"231748",title:"Dr.",name:"Kamal",middleName:null,surname:"Shah",slug:"kamal-shah",fullName:"Kamal Shah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"1119",title:"Exercise Physiology",slug:"exercise-physiology",parent:{title:"Physical Medicine and Rehabilitation",slug:"physical-medicine-and-rehabilitation"},numberOfBooks:5,numberOfAuthorsAndEditors:61,numberOfWosCitations:40,numberOfCrossrefCitations:22,numberOfDimensionsCitations:79,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"exercise-physiology",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9839",title:"Outdoor Recreation",subtitle:"Physiological and Psychological Effects on Health",isOpenForSubmission:!1,hash:"5f5a0d64267e32567daffa5b0c6a6972",slug:"outdoor-recreation-physiological-and-psychological-effects-on-health",bookSignature:"Hilde G. Nielsen",coverURL:"https://cdn.intechopen.com/books/images_new/9839.jpg",editedByType:"Edited by",editors:[{id:"158692",title:"Ph.D.",name:"Hilde G.",middleName:null,surname:"Nielsen",slug:"hilde-g.-nielsen",fullName:"Hilde G. Nielsen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7949",title:"Cardiorespiratory Fitness",subtitle:null,isOpenForSubmission:!1,hash:"fd6d8d7ee62bc8d443de2c5150c00535",slug:"cardiorespiratory-fitness",bookSignature:"Hasan Sözen",coverURL:"https://cdn.intechopen.com/books/images_new/7949.jpg",editedByType:"Edited by",editors:[{id:"161402",title:"Dr.",name:"Hasan",middleName:null,surname:"Sözen",slug:"hasan-sozen",fullName:"Hasan Sözen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6343",title:"Sport and Exercise Science",subtitle:null,isOpenForSubmission:!1,hash:"f02738ce8019136d4586b616f5670e9b",slug:"sport-and-exercise-science",bookSignature:"Matjaz Merc",coverURL:"https://cdn.intechopen.com/books/images_new/6343.jpg",editedByType:"Edited by",editors:[{id:"210233",title:"Dr.",name:"Matjaz",middleName:null,surname:"Merc",slug:"matjaz-merc",fullName:"Matjaz Merc"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3431",title:"Muscle Injuries in Sport Medicine",subtitle:null,isOpenForSubmission:!1,hash:"c234e7ea0b15db8dd5fa3d62698a6c64",slug:"muscle-injuries-in-sport-medicine",bookSignature:"Gian Nicola Bisciotti and Cristiano Eirale",coverURL:"https://cdn.intechopen.com/books/images_new/3431.jpg",editedByType:"Edited by",editors:[{id:"78940",title:"Prof.",name:"Gian Nicola",middleName:null,surname:"Bisciotti",slug:"gian-nicola-bisciotti",fullName:"Gian Nicola Bisciotti"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3398",title:"Current Issues in Sports and Exercise Medicine",subtitle:null,isOpenForSubmission:!1,hash:"fe3b3863298192755e00422f9fc2c8df",slug:"current-issues-in-sports-and-exercise-medicine",bookSignature:"Michael Hamlin, Nick Draper and Yaso Kathiravel",coverURL:"https://cdn.intechopen.com/books/images_new/3398.jpg",editedByType:"Edited by",editors:[{id:"162377",title:"Associate Prof.",name:"Michael",middleName:null,surname:"Hamlin",slug:"michael-hamlin",fullName:"Michael Hamlin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:5,mostCitedChapters:[{id:"44692",doi:"10.5772/55461",title:"Iron Supplementation and Physical Performance",slug:"iron-supplementation-and-physical-performance",totalDownloads:2925,totalCrossrefCites:1,totalDimensionsCites:34,book:{slug:"current-issues-in-sports-and-exercise-medicine",title:"Current Issues in Sports and Exercise Medicine",fullTitle:"Current Issues in Sports and Exercise Medicine"},signatures:"Chariklia K. Deli, Ioannis G. Fatouros, Yiannis Koutedakis and\nAthanasios Z. Jamurtas",authors:[{id:"74567",title:"Dr.",name:"Athanasios",middleName:null,surname:"Jamurtas",slug:"athanasios-jamurtas",fullName:"Athanasios Jamurtas"},{id:"136569",title:"Dr.",name:"Ioannis",middleName:null,surname:"Fatouros",slug:"ioannis-fatouros",fullName:"Ioannis Fatouros"},{id:"161217",title:"M.Sc.",name:"Chariklia",middleName:"K",surname:"Deli",slug:"chariklia-deli",fullName:"Chariklia Deli"},{id:"167822",title:"Prof.",name:"Yiannis",middleName:null,surname:"Koutedakis",slug:"yiannis-koutedakis",fullName:"Yiannis Koutedakis"}]},{id:"44614",doi:"10.5772/54234",title:"The Physiology of Sports Injuries and Repair Processes",slug:"the-physiology-of-sports-injuries-and-repair-processes",totalDownloads:6394,totalCrossrefCites:9,totalDimensionsCites:13,book:{slug:"current-issues-in-sports-and-exercise-medicine",title:"Current Issues in Sports and Exercise Medicine",fullTitle:"Current Issues in Sports and Exercise Medicine"},signatures:"Kelc Robi, Naranda Jakob, Kuhta Matevz and Vogrin Matjaz",authors:[{id:"159013",title:"Dr.",name:"Robi",middleName:null,surname:"Kelc",slug:"robi-kelc",fullName:"Robi Kelc"}]},{id:"44616",doi:"10.5772/54681",title:"Exercise and Immunity",slug:"exercise-and-immunity",totalDownloads:3395,totalCrossrefCites:3,totalDimensionsCites:6,book:{slug:"current-issues-in-sports-and-exercise-medicine",title:"Current Issues in Sports and Exercise Medicine",fullTitle:"Current Issues in Sports and Exercise Medicine"},signatures:"Hilde Grindvik Nielsen",authors:[{id:"158692",title:"Ph.D.",name:"Hilde G.",middleName:null,surname:"Nielsen",slug:"hilde-g.-nielsen",fullName:"Hilde G. Nielsen"}]}],mostDownloadedChaptersLast30Days:[{id:"58562",title:"Biokinetics: A South African Health Profession Evolving from Physical Education and Sport",slug:"biokinetics-a-south-african-health-profession-evolving-from-physical-education-and-sport",totalDownloads:1096,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"sport-and-exercise-science",title:"Sport and Exercise Science",fullTitle:"Sport and Exercise Science"},signatures:"Terry Jeremy Ellapen, Gert Lukas Strydom, Mariette Swanepoel,\nHenriette Hammill and Yvonne Paul",authors:[{id:"127909",title:"Prof.",name:"Gert Lukas",middleName:null,surname:"Strydom",slug:"gert-lukas-strydom",fullName:"Gert Lukas Strydom"},{id:"226652",title:"Dr.",name:"Terry",middleName:null,surname:"Ellapen",slug:"terry-ellapen",fullName:"Terry Ellapen"},{id:"233593",title:"Dr.",name:"Mariette",middleName:null,surname:"Swanepoel",slug:"mariette-swanepoel",fullName:"Mariette Swanepoel"},{id:"233594",title:"Dr.",name:"Henriette Valerie",middleName:null,surname:"Hammill",slug:"henriette-valerie-hammill",fullName:"Henriette Valerie Hammill"},{id:"233596",title:"Prof.",name:"Yvonne",middleName:null,surname:"Paul",slug:"yvonne-paul",fullName:"Yvonne Paul"}]},{id:"44616",title:"Exercise and Immunity",slug:"exercise-and-immunity",totalDownloads:3394,totalCrossrefCites:3,totalDimensionsCites:6,book:{slug:"current-issues-in-sports-and-exercise-medicine",title:"Current Issues in Sports and Exercise Medicine",fullTitle:"Current Issues in Sports and Exercise Medicine"},signatures:"Hilde Grindvik Nielsen",authors:[{id:"158692",title:"Ph.D.",name:"Hilde G.",middleName:null,surname:"Nielsen",slug:"hilde-g.-nielsen",fullName:"Hilde G. Nielsen"}]},{id:"44614",title:"The Physiology of Sports Injuries and Repair Processes",slug:"the-physiology-of-sports-injuries-and-repair-processes",totalDownloads:6391,totalCrossrefCites:9,totalDimensionsCites:13,book:{slug:"current-issues-in-sports-and-exercise-medicine",title:"Current Issues in Sports and Exercise Medicine",fullTitle:"Current Issues in Sports and Exercise Medicine"},signatures:"Kelc Robi, Naranda Jakob, Kuhta Matevz and Vogrin Matjaz",authors:[{id:"159013",title:"Dr.",name:"Robi",middleName:null,surname:"Kelc",slug:"robi-kelc",fullName:"Robi Kelc"}]},{id:"58218",title:"Biology of Stress and Physical Performance",slug:"biology-of-stress-and-physical-performance",totalDownloads:1389,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"sport-and-exercise-science",title:"Sport and Exercise Science",fullTitle:"Sport and Exercise Science"},signatures:"Jorge A. Sanhueza Silva, Carlos Bahamondes-Avila, Claudio\nHernández-Mosqueira and Luis A. Salazar Navarrete",authors:[{id:"211582",title:"Dr.",name:"Jorge",middleName:null,surname:"Sanhueza",slug:"jorge-sanhueza",fullName:"Jorge Sanhueza"},{id:"221070",title:"MSc.",name:"Carlos",middleName:null,surname:"Bahamondes",slug:"carlos-bahamondes",fullName:"Carlos Bahamondes"},{id:"221071",title:"Dr.",name:"Claudio",middleName:null,surname:"Hernandez Mosqueira",slug:"claudio-hernandez-mosqueira",fullName:"Claudio Hernandez Mosqueira"}]},{id:"44618",title:"Real and Simulated Altitude Training and Performance",slug:"real-and-simulated-altitude-training-and-performance",totalDownloads:3137,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"current-issues-in-sports-and-exercise-medicine",title:"Current Issues in Sports and Exercise Medicine",fullTitle:"Current Issues in Sports and Exercise Medicine"},signatures:"Michael J. Hamlin, Nick Draper and John Hellemans",authors:[{id:"162377",title:"Associate Prof.",name:"Michael",middleName:null,surname:"Hamlin",slug:"michael-hamlin",fullName:"Michael Hamlin"},{id:"162384",title:"Dr.",name:"John",middleName:null,surname:"Hellemans",slug:"john-hellemans",fullName:"John Hellemans"},{id:"163302",title:"Dr.",name:"Nick",middleName:null,surname:"Draper",slug:"nick-draper",fullName:"Nick Draper"}]},{id:"64166",title:"Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease",slug:"pulmonary-rehabilitation-in-chronic-obstructive-pulmonary-disease",totalDownloads:1044,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"cardiorespiratory-fitness",title:"Cardiorespiratory Fitness",fullTitle:"Cardiorespiratory Fitness"},signatures:"Ankur Girdhar, Puneet Agarwal and Amita Singh",authors:null},{id:"58153",title:"Overuse Injuries in Professional Ballet",slug:"overuse-injuries-in-professional-ballet",totalDownloads:885,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"sport-and-exercise-science",title:"Sport and Exercise Science",fullTitle:"Sport and Exercise Science"},signatures:"Francisco J. Sobrino and Pedro Guillen",authors:[{id:"218702",title:"Ph.D.",name:"Francisco J.",middleName:null,surname:"Sobrino",slug:"francisco-j.-sobrino",fullName:"Francisco J. Sobrino"}]},{id:"58233",title:"Diagnosis of Motor Habits during Backward Fall with Usage of Rotating Training Simulator",slug:"diagnosis-of-motor-habits-during-backward-fall-with-usage-of-rotating-training-simulator",totalDownloads:764,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"sport-and-exercise-science",title:"Sport and Exercise Science",fullTitle:"Sport and Exercise Science"},signatures:"Andrzej Mroczkowski and Dariusz Mosler",authors:[{id:"144247",title:"Dr.",name:"Andrzej",middleName:null,surname:"Mroczkowski",slug:"andrzej-mroczkowski",fullName:"Andrzej Mroczkowski"},{id:"221034",title:"Mr.",name:"Dariusz",middleName:null,surname:"Mosler",slug:"dariusz-mosler",fullName:"Dariusz Mosler"}]},{id:"71630",title:"Outdoor Recreation within the School Setting: A Physiological and Psychological Exploration",slug:"outdoor-recreation-within-the-school-setting-a-physiological-and-psychological-exploration",totalDownloads:290,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"outdoor-recreation-physiological-and-psychological-effects-on-health",title:"Outdoor Recreation",fullTitle:"Outdoor Recreation - Physiological and Psychological Effects on Health"},signatures:"Brendon Patrick Hyndman and Shirley Wyver",authors:[{id:"316357",title:"Dr.",name:"Brendon",middleName:null,surname:"Hyndman",slug:"brendon-hyndman",fullName:"Brendon Hyndman"},{id:"316615",title:"Dr.",name:"Shirley",middleName:null,surname:"Wyver",slug:"shirley-wyver",fullName:"Shirley Wyver"}]},{id:"44626",title:"Patellofemoral Instability: Diagnosis and Management",slug:"patellofemoral-instability-diagnosis-and-management",totalDownloads:3839,totalCrossrefCites:1,totalDimensionsCites:6,book:{slug:"current-issues-in-sports-and-exercise-medicine",title:"Current Issues in Sports and Exercise Medicine",fullTitle:"Current Issues in Sports and Exercise Medicine"},signatures:"Alexander Golant, Tony Quach and Jeffrey Rosen",authors:[{id:"157699",title:"Dr.",name:"Alexander",middleName:null,surname:"Golant",slug:"alexander-golant",fullName:"Alexander Golant"}]}],onlineFirstChaptersFilter:{topicSlug:"exercise-physiology",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"chapter.detail",path:"/books/telemedicine-techniques-and-applications/clinical-decision-support-systems",hash:"",query:{},params:{book:"telemedicine-techniques-and-applications",chapter:"clinical-decision-support-systems"},fullPath:"/books/telemedicine-techniques-and-applications/clinical-decision-support-systems",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()